| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 498 | 2024 | 12240 | 19.650 |
Why?
|
| Diet | 335 | 2025 | 8086 | 15.110 |
Why?
|
| Cardiovascular Diseases | 275 | 2025 | 15651 | 11.010 |
Why?
|
| Feeding Behavior | 117 | 2024 | 3211 | 9.060 |
Why?
|
| Diet, Mediterranean | 80 | 2024 | 746 | 8.740 |
Why?
|
| Dietary Fats | 93 | 2024 | 2002 | 8.540 |
Why?
|
| Coronary Disease | 138 | 2024 | 5912 | 8.260 |
Why?
|
| Obesity | 224 | 2024 | 13075 | 8.110 |
Why?
|
| Dietary Carbohydrates | 71 | 2024 | 894 | 7.910 |
Why?
|
| Life Style | 142 | 2024 | 3926 | 6.760 |
Why?
|
| Body Mass Index | 280 | 2024 | 13039 | 5.950 |
Why?
|
| Meat | 41 | 2024 | 588 | 5.780 |
Why?
|
| Weight Gain | 73 | 2024 | 2355 | 5.650 |
Why?
|
| Energy Intake | 63 | 2024 | 2140 | 5.600 |
Why?
|
| Risk Factors | 681 | 2024 | 74836 | 5.510 |
Why?
|
| Dairy Products | 28 | 2023 | 491 | 5.510 |
Why?
|
| Prospective Studies | 583 | 2024 | 54806 | 5.450 |
Why?
|
| Nuts | 43 | 2023 | 265 | 5.430 |
Why?
|
| Coffee | 33 | 2024 | 593 | 5.220 |
Why?
|
| Diet, Vegetarian | 21 | 2024 | 181 | 4.770 |
Why?
|
| Beverages | 41 | 2024 | 819 | 4.730 |
Why?
|
| Diabetes, Gestational | 53 | 2024 | 1264 | 4.440 |
Why?
|
| Fruit | 44 | 2023 | 1167 | 4.250 |
Why?
|
| Dietary Fiber | 43 | 2022 | 767 | 4.170 |
Why?
|
| Nurses | 84 | 2024 | 2505 | 3.860 |
Why?
|
| Middle Aged | 904 | 2025 | 223004 | 3.830 |
Why?
|
| Metabolomics | 38 | 2024 | 1668 | 3.700 |
Why?
|
| Overweight | 69 | 2024 | 2443 | 3.670 |
Why?
|
| Nutrition Policy | 22 | 2018 | 467 | 3.560 |
Why?
|
| Follow-Up Studies | 289 | 2024 | 39194 | 3.540 |
Why?
|
| Humans | 1478 | 2025 | 765956 | 3.540 |
Why?
|
| Cause of Death | 51 | 2024 | 3708 | 3.500 |
Why?
|
| Dietary Proteins | 39 | 2021 | 959 | 3.480 |
Why?
|
| Glycemic Index | 34 | 2024 | 400 | 3.480 |
Why?
|
| Vegetables | 43 | 2024 | 1200 | 3.460 |
Why?
|
| Adult | 773 | 2024 | 223038 | 3.460 |
Why?
|
| Sweetening Agents | 21 | 2024 | 291 | 3.450 |
Why?
|
| Female | 1049 | 2025 | 396101 | 3.370 |
Why?
|
| Body Weight | 54 | 2024 | 4622 | 3.230 |
Why?
|
| Proportional Hazards Models | 149 | 2024 | 12509 | 3.180 |
Why?
|
| Cohort Studies | 304 | 2024 | 41647 | 3.140 |
Why?
|
| Adiponectin | 48 | 2022 | 1119 | 3.120 |
Why?
|
| Risk Reduction Behavior | 23 | 2024 | 1123 | 3.030 |
Why?
|
| China | 102 | 2024 | 2385 | 3.010 |
Why?
|
| Dietary Sucrose | 16 | 2017 | 241 | 2.960 |
Why?
|
| Incidence | 213 | 2024 | 21480 | 2.900 |
Why?
|
| Polymorphism, Single Nucleotide | 153 | 2024 | 16047 | 2.890 |
Why?
|
| Caffeine | 22 | 2023 | 702 | 2.860 |
Why?
|
| Weight Loss | 42 | 2024 | 2710 | 2.810 |
Why?
|
| Diabetes Mellitus | 55 | 2024 | 5891 | 2.800 |
Why?
|
| Adiposity | 42 | 2024 | 1890 | 2.770 |
Why?
|
| Diabetic Angiopathies | 25 | 2015 | 805 | 2.750 |
Why?
|
| Aged | 546 | 2025 | 171114 | 2.650 |
Why?
|
| Diet, Carbohydrate-Restricted | 16 | 2023 | 263 | 2.600 |
Why?
|
| Diet Surveys | 52 | 2024 | 1159 | 2.590 |
Why?
|
| Exercise | 83 | 2024 | 5937 | 2.580 |
Why?
|
| Fatty Acids | 35 | 2024 | 1806 | 2.530 |
Why?
|
| Male | 725 | 2025 | 363691 | 2.510 |
Why?
|
| Linoleic Acid | 8 | 2020 | 157 | 2.430 |
Why?
|
| United States | 322 | 2024 | 72898 | 2.410 |
Why?
|
| Blood Glucose | 77 | 2024 | 6425 | 2.400 |
Why?
|
| Nutritional Status | 17 | 2024 | 1620 | 2.380 |
Why?
|
| Risk | 119 | 2021 | 9591 | 2.310 |
Why?
|
| Mortality | 30 | 2024 | 2904 | 2.270 |
Why?
|
| Lipids | 44 | 2023 | 3316 | 2.210 |
Why?
|
| Genetic Predisposition to Disease | 120 | 2023 | 18071 | 2.200 |
Why?
|
| Dietary Fats, Unsaturated | 10 | 2017 | 223 | 2.190 |
Why?
|
| Diabetes Complications | 16 | 2019 | 1316 | 2.180 |
Why?
|
| Multivariate Analysis | 120 | 2021 | 12057 | 2.150 |
Why?
|
| Nutrition Assessment | 30 | 2024 | 738 | 2.120 |
Why?
|
| Smoking | 94 | 2023 | 9081 | 2.110 |
Why?
|
| Food Preferences | 10 | 2020 | 397 | 2.020 |
Why?
|
| C-Reactive Protein | 53 | 2020 | 3850 | 2.000 |
Why?
|
| Fatty Acids, Omega-3 | 26 | 2023 | 1396 | 2.000 |
Why?
|
| Stroke | 59 | 2024 | 9747 | 1.990 |
Why?
|
| Nutritional Sciences | 8 | 2018 | 148 | 1.960 |
Why?
|
| Diet, Reducing | 17 | 2021 | 487 | 1.930 |
Why?
|
| Genome-Wide Association Study | 112 | 2024 | 12807 | 1.890 |
Why?
|
| Diet Records | 17 | 2024 | 425 | 1.870 |
Why?
|
| Case-Control Studies | 159 | 2024 | 22222 | 1.800 |
Why?
|
| Nutrition Surveys | 33 | 2022 | 1741 | 1.780 |
Why?
|
| Fatty Acids, Unsaturated | 15 | 2019 | 538 | 1.770 |
Why?
|
| Cholesterol, HDL | 29 | 2023 | 1811 | 1.640 |
Why?
|
| Neoplasms | 62 | 2024 | 22340 | 1.630 |
Why?
|
| Insulin Resistance | 47 | 2024 | 3985 | 1.610 |
Why?
|
| Trans Fatty Acids | 13 | 2023 | 155 | 1.610 |
Why?
|
| Food | 11 | 2024 | 764 | 1.580 |
Why?
|
| Dietary Supplements | 31 | 2024 | 3426 | 1.570 |
Why?
|
| Motor Activity | 26 | 2016 | 2704 | 1.570 |
Why?
|
| Inflammation | 46 | 2024 | 10850 | 1.560 |
Why?
|
| Chronic Disease | 30 | 2024 | 9347 | 1.560 |
Why?
|
| Juglans | 8 | 2022 | 45 | 1.550 |
Why?
|
| Epidemiologic Studies | 15 | 2022 | 677 | 1.530 |
Why?
|
| Alcohol Drinking | 39 | 2025 | 4040 | 1.500 |
Why?
|
| Genetic Variation | 36 | 2018 | 6610 | 1.400 |
Why?
|
| Magnesium | 10 | 2017 | 813 | 1.380 |
Why?
|
| Diet, Fat-Restricted | 9 | 2023 | 328 | 1.370 |
Why?
|
| Waist-Hip Ratio | 22 | 2019 | 520 | 1.360 |
Why?
|
| Amino Acids, Branched-Chain | 10 | 2023 | 266 | 1.330 |
Why?
|
| Longevity | 10 | 2024 | 1087 | 1.330 |
Why?
|
| Health Surveys | 51 | 2021 | 4056 | 1.320 |
Why?
|
| Meat Products | 6 | 2017 | 97 | 1.310 |
Why?
|
| Waist Circumference | 21 | 2020 | 933 | 1.290 |
Why?
|
| Heme | 6 | 2024 | 316 | 1.290 |
Why?
|
| Nutritive Value | 14 | 2019 | 351 | 1.290 |
Why?
|
| Cross-Sectional Studies | 103 | 2024 | 26313 | 1.270 |
Why?
|
| Sodium, Dietary | 6 | 2024 | 426 | 1.260 |
Why?
|
| Fatty Acids, Monounsaturated | 10 | 2019 | 190 | 1.240 |
Why?
|
| Receptors, Leptin | 7 | 2019 | 355 | 1.240 |
Why?
|
| Interleukin-6 | 24 | 2022 | 3222 | 1.240 |
Why?
|
| Insulin | 47 | 2022 | 6599 | 1.240 |
Why?
|
| Sleep | 22 | 2024 | 4812 | 1.220 |
Why?
|
| Iron | 9 | 2024 | 1816 | 1.210 |
Why?
|
| Carbohydrates | 9 | 2024 | 386 | 1.210 |
Why?
|
| Life Expectancy | 8 | 2024 | 1247 | 1.200 |
Why?
|
| Menarche | 11 | 2024 | 532 | 1.180 |
Why?
|
| Genetic Loci | 26 | 2017 | 2631 | 1.170 |
Why?
|
| Starch | 4 | 2018 | 81 | 1.170 |
Why?
|
| Health Behavior | 25 | 2018 | 2650 | 1.170 |
Why?
|
| Cholesterol | 23 | 2023 | 2898 | 1.150 |
Why?
|
| Prediabetic State | 9 | 2024 | 548 | 1.150 |
Why?
|
| Eating | 15 | 2024 | 1539 | 1.140 |
Why?
|
| Hypertension | 51 | 2024 | 8626 | 1.120 |
Why?
|
| Adipose Tissue | 22 | 2023 | 3312 | 1.110 |
Why?
|
| Odds Ratio | 71 | 2024 | 9649 | 1.100 |
Why?
|
| Obesity, Abdominal | 10 | 2024 | 370 | 1.100 |
Why?
|
| alpha-Linolenic Acid | 8 | 2016 | 145 | 1.090 |
Why?
|
| Myocardial Infarction | 48 | 2021 | 11501 | 1.050 |
Why?
|
| Genotype | 76 | 2019 | 13024 | 1.040 |
Why?
|
| Food, Organic | 4 | 2018 | 34 | 1.030 |
Why?
|
| Randomized Controlled Trials as Topic | 33 | 2024 | 10383 | 1.030 |
Why?
|
| Risk Assessment | 74 | 2024 | 24283 | 1.020 |
Why?
|
| E-Selectin | 12 | 2010 | 576 | 1.020 |
Why?
|
| DNA Methylation | 13 | 2024 | 4424 | 1.010 |
Why?
|
| Carnitine | 11 | 2021 | 253 | 1.000 |
Why?
|
| Solanum tuberosum | 4 | 2016 | 48 | 1.000 |
Why?
|
| Triglycerides | 22 | 2020 | 2441 | 1.000 |
Why?
|
| Fatty Acids, Omega-6 | 8 | 2020 | 226 | 0.990 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 13 | 2017 | 347 | 0.990 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 9 | 2017 | 1657 | 0.990 |
Why?
|
| Diet Therapy | 3 | 2021 | 149 | 0.950 |
Why?
|
| Cooking | 10 | 2020 | 327 | 0.930 |
Why?
|
| Patient Compliance | 9 | 2015 | 2692 | 0.920 |
Why?
|
| Emulsifying Agents | 1 | 2024 | 6 | 0.920 |
Why?
|
| Health Personnel | 31 | 2020 | 3390 | 0.920 |
Why?
|
| Food Additives | 1 | 2024 | 23 | 0.920 |
Why?
|
| Longitudinal Studies | 55 | 2024 | 14749 | 0.910 |
Why?
|
| Physical Fitness | 8 | 2014 | 742 | 0.910 |
Why?
|
| Folic Acid | 17 | 2023 | 1339 | 0.910 |
Why?
|
| Health Promotion | 9 | 2022 | 2208 | 0.900 |
Why?
|
| Evidence-Based Medicine | 11 | 2023 | 3685 | 0.900 |
Why?
|
| Body Composition | 18 | 2023 | 2439 | 0.900 |
Why?
|
| Self Report | 21 | 2024 | 3771 | 0.900 |
Why?
|
| Starvation | 4 | 2016 | 141 | 0.900 |
Why?
|
| Public Health | 10 | 2022 | 2680 | 0.890 |
Why?
|
| Calcium, Dietary | 8 | 2023 | 526 | 0.890 |
Why?
|
| Metabolome | 13 | 2024 | 1005 | 0.890 |
Why?
|
| Postmenopause | 26 | 2024 | 2515 | 0.890 |
Why?
|
| Preconception Care | 5 | 2019 | 143 | 0.890 |
Why?
|
| Methylamines | 9 | 2021 | 136 | 0.890 |
Why?
|
| Prevalence | 57 | 2024 | 15839 | 0.880 |
Why?
|
| Food Labeling | 2 | 2016 | 181 | 0.880 |
Why?
|
| Plant Oils | 10 | 2019 | 199 | 0.880 |
Why?
|
| Retinol-Binding Proteins, Plasma | 11 | 2017 | 94 | 0.880 |
Why?
|
| Dyslipidemias | 10 | 2024 | 869 | 0.870 |
Why?
|
| Vitamin D | 17 | 2023 | 3272 | 0.870 |
Why?
|
| Blood Pressure | 33 | 2024 | 8532 | 0.870 |
Why?
|
| Fishes | 12 | 2022 | 606 | 0.860 |
Why?
|
| Hyperglycemia | 12 | 2022 | 1393 | 0.860 |
Why?
|
| Fasting | 21 | 2019 | 1606 | 0.860 |
Why?
|
| Adipokines | 8 | 2016 | 308 | 0.850 |
Why?
|
| Television | 10 | 2013 | 409 | 0.850 |
Why?
|
| Linear Models | 35 | 2019 | 5876 | 0.840 |
Why?
|
| Potassium | 5 | 2024 | 1311 | 0.840 |
Why?
|
| Seeds | 5 | 2016 | 124 | 0.840 |
Why?
|
| Occupations | 3 | 2014 | 516 | 0.840 |
Why?
|
| Iron, Dietary | 7 | 2024 | 148 | 0.830 |
Why?
|
| Tea | 11 | 2024 | 290 | 0.830 |
Why?
|
| Endothelium, Vascular | 13 | 2009 | 4427 | 0.820 |
Why?
|
| Coronary Artery Disease | 17 | 2020 | 6546 | 0.820 |
Why?
|
| Cholesterol, Dietary | 6 | 2013 | 223 | 0.820 |
Why?
|
| Erythrocytes | 9 | 2020 | 2395 | 0.810 |
Why?
|
| Women's Health | 20 | 2020 | 2084 | 0.810 |
Why?
|
| Health Status | 21 | 2023 | 4080 | 0.810 |
Why?
|
| Polymorphism, Genetic | 22 | 2020 | 4247 | 0.810 |
Why?
|
| Age Factors | 65 | 2020 | 18380 | 0.810 |
Why?
|
| Depression | 16 | 2016 | 8230 | 0.800 |
Why?
|
| Metabolic Diseases | 6 | 2019 | 687 | 0.800 |
Why?
|
| Inflammation Mediators | 11 | 2020 | 1884 | 0.790 |
Why?
|
| Seafood | 8 | 2019 | 395 | 0.780 |
Why?
|
| Time Factors | 79 | 2024 | 40065 | 0.770 |
Why?
|
| Body Size | 11 | 2017 | 459 | 0.760 |
Why?
|
| Research Design | 16 | 2023 | 6208 | 0.750 |
Why?
|
| Gene Frequency | 30 | 2024 | 3624 | 0.750 |
Why?
|
| Milk | 4 | 2023 | 436 | 0.750 |
Why?
|
| Aging | 26 | 2024 | 8731 | 0.750 |
Why?
|
| Body Height | 14 | 2017 | 1562 | 0.750 |
Why?
|
| Peripheral Vascular Diseases | 5 | 2008 | 516 | 0.740 |
Why?
|
| Food Handling | 9 | 2020 | 158 | 0.740 |
Why?
|
| Lipid Metabolism | 13 | 2024 | 1892 | 0.740 |
Why?
|
| Anthropometry | 18 | 2018 | 1338 | 0.740 |
Why?
|
| Snoring | 6 | 2017 | 211 | 0.730 |
Why?
|
| Pregnancy | 71 | 2024 | 30258 | 0.730 |
Why?
|
| Carbonated Beverages | 10 | 2023 | 209 | 0.730 |
Why?
|
| Epidemics | 3 | 2024 | 514 | 0.730 |
Why?
|
| Health | 4 | 2015 | 397 | 0.730 |
Why?
|
| Ceramides | 2 | 2024 | 201 | 0.710 |
Why?
|
| Sleep Deprivation | 5 | 2015 | 845 | 0.710 |
Why?
|
| Nutrition Therapy | 2 | 2021 | 101 | 0.710 |
Why?
|
| Energy Metabolism | 15 | 2017 | 2892 | 0.700 |
Why?
|
| Young Adult | 83 | 2023 | 59886 | 0.690 |
Why?
|
| Resistin | 6 | 2012 | 174 | 0.690 |
Why?
|
| Melatonin | 2 | 2024 | 674 | 0.680 |
Why?
|
| Aged, 80 and over | 81 | 2024 | 59488 | 0.680 |
Why?
|
| Sex Factors | 39 | 2020 | 10602 | 0.680 |
Why?
|
| Leptin | 13 | 2019 | 1596 | 0.680 |
Why?
|
| Iron Overload | 6 | 2016 | 245 | 0.680 |
Why?
|
| Drinking Behavior | 4 | 2014 | 101 | 0.670 |
Why?
|
| Abdominal Fat | 5 | 2010 | 217 | 0.670 |
Why?
|
| Yogurt | 6 | 2022 | 71 | 0.670 |
Why?
|
| Primary Prevention | 8 | 2019 | 1187 | 0.660 |
Why?
|
| Hypercholesterolemia | 12 | 2016 | 1149 | 0.660 |
Why?
|
| Eggs | 7 | 2020 | 182 | 0.650 |
Why?
|
| Vitamin D Deficiency | 10 | 2017 | 1348 | 0.650 |
Why?
|
| Environmental Exposure | 12 | 2021 | 4543 | 0.640 |
Why?
|
| Hypoglycemic Agents | 11 | 2024 | 3110 | 0.640 |
Why?
|
| Environment | 6 | 2024 | 1114 | 0.640 |
Why?
|
| Fabaceae | 7 | 2024 | 103 | 0.630 |
Why?
|
| Feces | 5 | 2024 | 1504 | 0.630 |
Why?
|
| Satiation | 3 | 2023 | 84 | 0.630 |
Why?
|
| Bisexuality | 2 | 2018 | 295 | 0.630 |
Why?
|
| Heterosexuality | 2 | 2018 | 308 | 0.620 |
Why?
|
| Colorectal Neoplasms | 20 | 2021 | 6942 | 0.620 |
Why?
|
| Nails | 5 | 2014 | 298 | 0.610 |
Why?
|
| Epigenesis, Genetic | 9 | 2024 | 3819 | 0.610 |
Why?
|
| Proteins | 19 | 2016 | 5995 | 0.610 |
Why?
|
| Confidence Intervals | 24 | 2021 | 2910 | 0.600 |
Why?
|
| Caloric Restriction | 2 | 2019 | 304 | 0.600 |
Why?
|
| Hyperinsulinism | 5 | 2023 | 402 | 0.600 |
Why?
|
| Epidemiologic Methods | 7 | 2021 | 1326 | 0.600 |
Why?
|
| Menopause | 12 | 2023 | 1659 | 0.590 |
Why?
|
| Glucose Intolerance | 10 | 2019 | 580 | 0.590 |
Why?
|
| Lignans | 4 | 2022 | 82 | 0.590 |
Why?
|
| Phytosterols | 2 | 2023 | 55 | 0.590 |
Why?
|
| C-Peptide | 13 | 2023 | 443 | 0.580 |
Why?
|
| Apolipoproteins B | 4 | 2009 | 384 | 0.580 |
Why?
|
| Tryptophan | 7 | 2023 | 483 | 0.570 |
Why?
|
| Regression Analysis | 24 | 2021 | 6321 | 0.570 |
Why?
|
| Forecasting | 6 | 2017 | 2936 | 0.570 |
Why?
|
| Logistic Models | 44 | 2021 | 13266 | 0.570 |
Why?
|
| Cardiovascular System | 3 | 2022 | 841 | 0.570 |
Why?
|
| Fast Foods | 4 | 2023 | 220 | 0.570 |
Why?
|
| TCF Transcription Factors | 2 | 2009 | 137 | 0.560 |
Why?
|
| Glutamine | 6 | 2023 | 576 | 0.560 |
Why?
|
| Satiety Response | 2 | 2009 | 47 | 0.560 |
Why?
|
| Anti-Obesity Agents | 3 | 2024 | 242 | 0.550 |
Why?
|
| Potassium, Dietary | 3 | 2024 | 103 | 0.550 |
Why?
|
| Immune System Diseases | 1 | 2019 | 251 | 0.550 |
Why?
|
| Plants | 8 | 2023 | 331 | 0.550 |
Why?
|
| Apolipoprotein C-III | 4 | 2021 | 209 | 0.540 |
Why?
|
| Cholesterol, LDL | 13 | 2022 | 2393 | 0.540 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 1087 | 0.540 |
Why?
|
| Atherosclerosis | 8 | 2023 | 3425 | 0.540 |
Why?
|
| Linkage Disequilibrium | 14 | 2013 | 1997 | 0.540 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2008 | 226 | 0.530 |
Why?
|
| Smoking Cessation | 7 | 2020 | 2084 | 0.530 |
Why?
|
| Myocardial Ischemia | 6 | 2011 | 2128 | 0.520 |
Why?
|
| Soybean Proteins | 4 | 2011 | 55 | 0.520 |
Why?
|
| Adolescent | 86 | 2024 | 88832 | 0.520 |
Why?
|
| Homosexuality, Female | 1 | 2018 | 171 | 0.520 |
Why?
|
| Glutamic Acid | 6 | 2023 | 1180 | 0.520 |
Why?
|
| Acids | 1 | 2016 | 125 | 0.520 |
Why?
|
| Hyperhomocysteinemia | 1 | 2016 | 117 | 0.510 |
Why?
|
| Nutritional Physiological Phenomena | 7 | 2019 | 357 | 0.500 |
Why?
|
| Meta-Analysis as Topic | 17 | 2023 | 1370 | 0.500 |
Why?
|
| Alleles | 34 | 2021 | 6897 | 0.490 |
Why?
|
| Premature Birth | 5 | 2023 | 1829 | 0.490 |
Why?
|
| Brain Ischemia | 12 | 2019 | 3000 | 0.490 |
Why?
|
| Carotid Artery, Common | 2 | 2008 | 172 | 0.490 |
Why?
|
| Veterans | 8 | 2024 | 2664 | 0.490 |
Why?
|
| Resorcinols | 3 | 2019 | 41 | 0.490 |
Why?
|
| Overnutrition | 2 | 2021 | 25 | 0.490 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 5 | 2019 | 152 | 0.490 |
Why?
|
| Environmental Pollutants | 5 | 2018 | 1291 | 0.490 |
Why?
|
| Spain | 9 | 2019 | 483 | 0.480 |
Why?
|
| Birth Weight | 12 | 2024 | 2122 | 0.480 |
Why?
|
| Fructose | 2 | 2023 | 286 | 0.480 |
Why?
|
| Receptor, Melanocortin, Type 4 | 4 | 2015 | 132 | 0.470 |
Why?
|
| Reference Values | 15 | 2016 | 4908 | 0.470 |
Why?
|
| Nutritional Requirements | 1 | 2016 | 276 | 0.460 |
Why?
|
| Interleukin-18 | 4 | 2011 | 251 | 0.460 |
Why?
|
| Phenols | 3 | 2023 | 522 | 0.460 |
Why?
|
| Aspartate Aminotransferases | 4 | 2020 | 415 | 0.460 |
Why?
|
| Zinc | 5 | 2019 | 675 | 0.460 |
Why?
|
| Prenatal Exposure Delayed Effects | 11 | 2024 | 2531 | 0.460 |
Why?
|
| Factor Analysis, Statistical | 14 | 2021 | 999 | 0.450 |
Why?
|
| Metals | 4 | 2019 | 710 | 0.450 |
Why?
|
| Clinical Trials as Topic | 11 | 2020 | 8041 | 0.450 |
Why?
|
| Fats | 2 | 2019 | 99 | 0.450 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2014 | 827 | 0.440 |
Why?
|
| Biological Specimen Banks | 3 | 2021 | 786 | 0.440 |
Why?
|
| Chromium | 2 | 2004 | 132 | 0.440 |
Why?
|
| Gallstones | 5 | 2018 | 285 | 0.440 |
Why?
|
| Plant Preparations | 1 | 2014 | 93 | 0.430 |
Why?
|
| Economic Development | 1 | 2014 | 72 | 0.430 |
Why?
|
| Lipase | 2 | 2006 | 320 | 0.430 |
Why?
|
| Inhalation Exposure | 3 | 2014 | 432 | 0.420 |
Why?
|
| Drinking | 2 | 2012 | 196 | 0.420 |
Why?
|
| Ferritins | 7 | 2013 | 600 | 0.420 |
Why?
|
| Biomedical Research | 6 | 2021 | 3458 | 0.420 |
Why?
|
| Alanine Transaminase | 4 | 2019 | 607 | 0.420 |
Why?
|
| Medicine | 2 | 2021 | 942 | 0.420 |
Why?
|
| Breast Neoplasms | 26 | 2024 | 21056 | 0.410 |
Why?
|
| Apolipoproteins A | 3 | 2012 | 94 | 0.410 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2015 | 410 | 0.410 |
Why?
|
| Walking | 10 | 2020 | 1198 | 0.410 |
Why?
|
| Disclosure | 1 | 2018 | 756 | 0.410 |
Why?
|
| Western World | 1 | 2012 | 26 | 0.410 |
Why?
|
| Sulfonylurea Compounds | 1 | 2014 | 221 | 0.410 |
Why?
|
| Reproducibility of Results | 27 | 2022 | 20125 | 0.400 |
Why?
|
| Predictive Value of Tests | 20 | 2024 | 15398 | 0.400 |
Why?
|
| Absorptiometry, Photon | 7 | 2017 | 1707 | 0.400 |
Why?
|
| Health Transition | 1 | 2012 | 35 | 0.400 |
Why?
|
| Methylmercury Compounds | 1 | 2013 | 103 | 0.400 |
Why?
|
| Secondary Prevention | 4 | 2014 | 1472 | 0.400 |
Why?
|
| Phosphatidylcholines | 4 | 2024 | 403 | 0.400 |
Why?
|
| Periodontitis | 4 | 2021 | 576 | 0.400 |
Why?
|
| Choline | 5 | 2024 | 510 | 0.400 |
Why?
|
| Chromatography, Liquid | 10 | 2023 | 990 | 0.400 |
Why?
|
| Body Fat Distribution | 6 | 2015 | 246 | 0.400 |
Why?
|
| Animals | 71 | 2024 | 168759 | 0.390 |
Why?
|
| Models, Genetic | 12 | 2018 | 3448 | 0.390 |
Why?
|
| Quantitative Trait Loci | 17 | 2017 | 2140 | 0.390 |
Why?
|
| Phthalic Acids | 2 | 2014 | 485 | 0.390 |
Why?
|
| Disease Susceptibility | 3 | 2017 | 1789 | 0.390 |
Why?
|
| Bariatric Surgery | 6 | 2015 | 997 | 0.390 |
Why?
|
| Cholesterol Ester Transfer Proteins | 2 | 2014 | 111 | 0.380 |
Why?
|
| Uric Acid | 4 | 2014 | 809 | 0.380 |
Why?
|
| Wine | 2 | 2025 | 172 | 0.380 |
Why?
|
| Socioeconomic Factors | 20 | 2019 | 7836 | 0.380 |
Why?
|
| Disease Management | 3 | 2017 | 2535 | 0.380 |
Why?
|
| Urban Population | 9 | 2020 | 2040 | 0.380 |
Why?
|
| Age of Onset | 7 | 2024 | 3343 | 0.380 |
Why?
|
| Child | 60 | 2024 | 80563 | 0.380 |
Why?
|
| Citric Acid Cycle | 3 | 2023 | 228 | 0.380 |
Why?
|
| Selenium | 3 | 2014 | 419 | 0.370 |
Why?
|
| 4-Butyrolactone | 4 | 2022 | 60 | 0.370 |
Why?
|
| Industry | 1 | 2013 | 362 | 0.370 |
Why?
|
| Fatty Acid Desaturases | 4 | 2020 | 102 | 0.370 |
Why?
|
| ABO Blood-Group System | 2 | 2012 | 380 | 0.360 |
Why?
|
| Glomerular Filtration Rate | 10 | 2018 | 2233 | 0.360 |
Why?
|
| Atrial Fibrillation | 7 | 2023 | 5189 | 0.360 |
Why?
|
| Health Status Indicators | 2 | 2016 | 966 | 0.360 |
Why?
|
| Heart Failure | 8 | 2022 | 11840 | 0.360 |
Why?
|
| Tunica Media | 2 | 2008 | 107 | 0.360 |
Why?
|
| Infant Mortality | 1 | 2015 | 751 | 0.350 |
Why?
|
| Milk Proteins | 1 | 2011 | 161 | 0.350 |
Why?
|
| Comorbidity | 23 | 2020 | 10563 | 0.350 |
Why?
|
| Receptors, Cell Surface | 2 | 2012 | 2817 | 0.350 |
Why?
|
| Estrogen Replacement Therapy | 9 | 2018 | 1206 | 0.350 |
Why?
|
| Menopause, Premature | 4 | 2022 | 124 | 0.350 |
Why?
|
| Saliva | 3 | 2024 | 851 | 0.350 |
Why?
|
| Amino Acids | 7 | 2023 | 1709 | 0.340 |
Why?
|
| Liver | 10 | 2024 | 7562 | 0.340 |
Why?
|
| Benzhydryl Compounds | 2 | 2014 | 939 | 0.340 |
Why?
|
| Tobacco, Smokeless | 3 | 2013 | 132 | 0.340 |
Why?
|
| Europe | 14 | 2024 | 3423 | 0.340 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 1053 | 0.340 |
Why?
|
| Azetidines | 1 | 2011 | 150 | 0.340 |
Why?
|
| Flavonoids | 4 | 2016 | 448 | 0.330 |
Why?
|
| Infant, Premature | 4 | 2015 | 2122 | 0.330 |
Why?
|
| Kidney | 10 | 2018 | 7066 | 0.330 |
Why?
|
| Citrus | 2 | 2024 | 49 | 0.330 |
Why?
|
| Food Hypersensitivity | 3 | 2024 | 737 | 0.330 |
Why?
|
| Lipoproteins, HDL | 5 | 2022 | 674 | 0.330 |
Why?
|
| Adolescent Behavior | 3 | 2012 | 1185 | 0.330 |
Why?
|
| Apolipoprotein A-I | 3 | 2020 | 304 | 0.330 |
Why?
|
| Heme Oxygenase-1 | 5 | 2013 | 364 | 0.330 |
Why?
|
| Kynurenine | 4 | 2023 | 142 | 0.330 |
Why?
|
| Health Policy | 3 | 2020 | 2698 | 0.320 |
Why?
|
| Muscle Strength | 1 | 2014 | 637 | 0.320 |
Why?
|
| Haplotypes | 11 | 2012 | 2728 | 0.320 |
Why?
|
| Prognosis | 28 | 2020 | 29921 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2018 | 3446 | 0.320 |
Why?
|
| Self Disclosure | 2 | 2008 | 248 | 0.320 |
Why?
|
| Molecular Weight | 8 | 2016 | 2163 | 0.320 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2012 | 456 | 0.320 |
Why?
|
| Lectins, C-Type | 1 | 2012 | 592 | 0.310 |
Why?
|
| Periodontal Diseases | 3 | 2024 | 453 | 0.310 |
Why?
|
| Child, Preschool | 28 | 2024 | 42500 | 0.310 |
Why?
|
| Cost of Illness | 5 | 2020 | 1950 | 0.310 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2018 | 4058 | 0.310 |
Why?
|
| Intra-Abdominal Fat | 5 | 2024 | 623 | 0.310 |
Why?
|
| Tunica Intima | 2 | 2008 | 455 | 0.310 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2008 | 23 | 0.310 |
Why?
|
| Asia | 4 | 2020 | 628 | 0.310 |
Why?
|
| Homocysteine | 3 | 2014 | 638 | 0.310 |
Why?
|
| Gestational Age | 6 | 2024 | 3613 | 0.300 |
Why?
|
| Sodium | 3 | 2024 | 1591 | 0.300 |
Why?
|
| Triticum | 2 | 2019 | 92 | 0.300 |
Why?
|
| Metformin | 3 | 2024 | 904 | 0.300 |
Why?
|
| Arginine | 4 | 2022 | 933 | 0.300 |
Why?
|
| Intercellular Adhesion Molecule-1 | 11 | 2020 | 1132 | 0.300 |
Why?
|
| Acute-Phase Proteins | 3 | 2014 | 252 | 0.290 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 10 | 2013 | 694 | 0.290 |
Why?
|
| Membrane Transport Proteins | 3 | 2012 | 1028 | 0.290 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2024 | 395 | 0.290 |
Why?
|
| Puberty | 2 | 2024 | 491 | 0.290 |
Why?
|
| Metabolic Networks and Pathways | 7 | 2020 | 798 | 0.290 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 8 | 2023 | 3247 | 0.290 |
Why?
|
| Morbidity | 4 | 2022 | 1749 | 0.290 |
Why?
|
| Frail Elderly | 6 | 2022 | 785 | 0.290 |
Why?
|
| Carotid Artery Diseases | 3 | 2018 | 874 | 0.290 |
Why?
|
| Leukocytes | 5 | 2020 | 2027 | 0.290 |
Why?
|
| Genetic Association Studies | 12 | 2015 | 2741 | 0.290 |
Why?
|
| Work Schedule Tolerance | 1 | 2011 | 554 | 0.280 |
Why?
|
| Water | 2 | 2023 | 1417 | 0.280 |
Why?
|
| Postprandial Period | 3 | 2024 | 319 | 0.280 |
Why?
|
| Membrane Proteins | 11 | 2017 | 7851 | 0.280 |
Why?
|
| Ghrelin | 1 | 2009 | 255 | 0.280 |
Why?
|
| Lipoprotein(a) | 4 | 2020 | 488 | 0.280 |
Why?
|
| Heart Rate | 6 | 2018 | 4203 | 0.280 |
Why?
|
| Activities of Daily Living | 2 | 2014 | 2415 | 0.280 |
Why?
|
| Rural Population | 10 | 2021 | 2317 | 0.280 |
Why?
|
| Isoflavones | 2 | 2020 | 139 | 0.280 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2007 | 126 | 0.280 |
Why?
|
| Blood | 2 | 2020 | 597 | 0.280 |
Why?
|
| Appetite | 2 | 2023 | 247 | 0.280 |
Why?
|
| Retinol-Binding Proteins | 1 | 2007 | 67 | 0.270 |
Why?
|
| Disease Progression | 11 | 2024 | 13631 | 0.270 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2007 | 145 | 0.270 |
Why?
|
| Spirituality | 2 | 2021 | 430 | 0.270 |
Why?
|
| Nutrigenomics | 2 | 2018 | 23 | 0.270 |
Why?
|
| Spine | 1 | 2013 | 1128 | 0.270 |
Why?
|
| Hip Fractures | 2 | 2024 | 997 | 0.270 |
Why?
|
| Hemochromatosis | 1 | 2008 | 175 | 0.270 |
Why?
|
| Plants, Toxic | 2 | 1997 | 70 | 0.270 |
Why?
|
| Models, Statistical | 12 | 2016 | 5089 | 0.270 |
Why?
|
| Genome, Human | 11 | 2017 | 4448 | 0.260 |
Why?
|
| Gout | 2 | 2024 | 620 | 0.260 |
Why?
|
| Chromosome Mapping | 8 | 2017 | 4618 | 0.260 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 4 | 2017 | 416 | 0.260 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2022 | 1896 | 0.260 |
Why?
|
| Vitamin D-Binding Protein | 2 | 2017 | 129 | 0.260 |
Why?
|
| Phlebotomy | 1 | 2007 | 138 | 0.260 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 2 | 2017 | 160 | 0.260 |
Why?
|
| Hormone Replacement Therapy | 4 | 2020 | 753 | 0.260 |
Why?
|
| Plant Proteins | 5 | 2023 | 374 | 0.250 |
Why?
|
| Amino Acids, Aromatic | 2 | 2018 | 36 | 0.250 |
Why?
|
| Insurance Coverage | 1 | 2017 | 1944 | 0.250 |
Why?
|
| Food Supply | 4 | 2021 | 544 | 0.250 |
Why?
|
| Thinness | 4 | 2016 | 482 | 0.250 |
Why?
|
| Age Distribution | 13 | 2017 | 2858 | 0.250 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2007 | 393 | 0.250 |
Why?
|
| Tandem Mass Spectrometry | 7 | 2023 | 1192 | 0.250 |
Why?
|
| Mendelian Randomization Analysis | 6 | 2020 | 1044 | 0.250 |
Why?
|
| Fish Oils | 5 | 2017 | 483 | 0.250 |
Why?
|
| Attitude to Health | 5 | 2015 | 2020 | 0.250 |
Why?
|
| Tartrates | 1 | 2025 | 13 | 0.240 |
Why?
|
| Cross-Over Studies | 7 | 2024 | 2108 | 0.240 |
Why?
|
| Asthma | 10 | 2024 | 6270 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 2013 | 533 | 0.240 |
Why?
|
| Taiwan | 4 | 2018 | 521 | 0.240 |
Why?
|
| Cheese | 3 | 2019 | 39 | 0.240 |
Why?
|
| Insurance, Health | 1 | 2017 | 2520 | 0.240 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2006 | 729 | 0.240 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2012 | 1365 | 0.240 |
Why?
|
| Anticholesteremic Agents | 2 | 2011 | 970 | 0.240 |
Why?
|
| Araceae | 2 | 2024 | 18 | 0.240 |
Why?
|
| Fibrinolysis | 2 | 2008 | 331 | 0.230 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2015 | 84 | 0.230 |
Why?
|
| Cation Transport Proteins | 3 | 2013 | 325 | 0.230 |
Why?
|
| Coal | 3 | 2018 | 123 | 0.230 |
Why?
|
| Bone Density | 2 | 2015 | 3491 | 0.230 |
Why?
|
| Membrane Glycoproteins | 4 | 2014 | 3690 | 0.230 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 1292 | 0.230 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 256 | 0.220 |
Why?
|
| Genetic Markers | 9 | 2014 | 2601 | 0.220 |
Why?
|
| Ornithine | 3 | 2018 | 80 | 0.220 |
Why?
|
| Chaperonin 60 | 3 | 2008 | 97 | 0.220 |
Why?
|
| Intermittent Claudication | 1 | 2006 | 300 | 0.220 |
Why?
|
| Lactation | 3 | 2022 | 391 | 0.220 |
Why?
|
| Central Nervous System Stimulants | 2 | 2017 | 1166 | 0.220 |
Why?
|
| Survival Rate | 11 | 2019 | 12795 | 0.220 |
Why?
|
| Plants, Edible | 1 | 2003 | 29 | 0.220 |
Why?
|
| Habits | 3 | 2018 | 147 | 0.220 |
Why?
|
| Kidney Failure, Chronic | 3 | 2012 | 2495 | 0.220 |
Why?
|
| Antigens, CD | 2 | 2012 | 4025 | 0.220 |
Why?
|
| Mothers | 5 | 2022 | 2208 | 0.220 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2022 | 3733 | 0.220 |
Why?
|
| KCNQ1 Potassium Channel | 3 | 2014 | 103 | 0.210 |
Why?
|
| Pregnancy Complications | 4 | 2016 | 2971 | 0.210 |
Why?
|
| Mass Spectrometry | 4 | 2017 | 2194 | 0.210 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2005 | 361 | 0.210 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2023 | 389 | 0.210 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 707 | 0.210 |
Why?
|
| Bilirubin | 2 | 2017 | 439 | 0.210 |
Why?
|
| Lipoproteins | 4 | 2019 | 866 | 0.210 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2005 | 308 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2013 | 4348 | 0.210 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2019 | 1090 | 0.210 |
Why?
|
| Telomere | 3 | 2014 | 943 | 0.210 |
Why?
|
| Denmark | 7 | 2019 | 774 | 0.210 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2010 | 393 | 0.210 |
Why?
|
| Glucose | 7 | 2023 | 4335 | 0.200 |
Why?
|
| Circadian Rhythm | 4 | 2017 | 2590 | 0.200 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 710 | 0.200 |
Why?
|
| Breast Feeding | 8 | 2024 | 1363 | 0.200 |
Why?
|
| Arachidonic Acid | 3 | 2019 | 430 | 0.200 |
Why?
|
| Peripheral Arterial Disease | 3 | 2022 | 1311 | 0.200 |
Why?
|
| Laminin | 2 | 2015 | 404 | 0.200 |
Why?
|
| Principal Component Analysis | 3 | 2016 | 951 | 0.200 |
Why?
|
| gamma-Tocopherol | 1 | 2022 | 29 | 0.200 |
Why?
|
| Persea | 1 | 2022 | 17 | 0.200 |
Why?
|
| Docosahexaenoic Acids | 5 | 2023 | 916 | 0.200 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2015 | 1151 | 0.190 |
Why?
|
| Tobacco Use Disorder | 2 | 1999 | 708 | 0.190 |
Why?
|
| Dehydroepiandrosterone Sulfate | 2 | 2013 | 238 | 0.190 |
Why?
|
| Data Interpretation, Statistical | 6 | 2011 | 2686 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2016 | 3807 | 0.190 |
Why?
|
| Infant, Newborn | 16 | 2024 | 26349 | 0.190 |
Why?
|
| Smoke | 4 | 2018 | 243 | 0.190 |
Why?
|
| Food Analysis | 2 | 2001 | 104 | 0.190 |
Why?
|
| Blood Donors | 1 | 2004 | 342 | 0.190 |
Why?
|
| Vitamin K 1 | 3 | 2006 | 41 | 0.190 |
Why?
|
| Religion | 2 | 2021 | 376 | 0.190 |
Why?
|
| Digestive System Neoplasms | 1 | 2021 | 82 | 0.190 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2006 | 1568 | 0.190 |
Why?
|
| Cerebrovascular Disorders | 3 | 2012 | 1470 | 0.190 |
Why?
|
| Statistics as Topic | 7 | 2017 | 2352 | 0.180 |
Why?
|
| Survival Analysis | 10 | 2021 | 10070 | 0.180 |
Why?
|
| Mexican Americans | 2 | 2016 | 165 | 0.180 |
Why?
|
| Phenylpropionates | 2 | 2019 | 34 | 0.180 |
Why?
|
| Wood | 2 | 2020 | 95 | 0.180 |
Why?
|
| Cholesterol Esters | 2 | 2018 | 68 | 0.180 |
Why?
|
| Carotid Stenosis | 1 | 2008 | 861 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2010 | 852 | 0.180 |
Why?
|
| Genomics | 4 | 2015 | 5929 | 0.180 |
Why?
|
| Neuropeptide Y | 2 | 2012 | 194 | 0.180 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2012 | 45 | 0.180 |
Why?
|
| Glucose Tolerance Test | 7 | 2022 | 1180 | 0.180 |
Why?
|
| Antidepressive Agents | 6 | 2015 | 2897 | 0.180 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2019 | 742 | 0.180 |
Why?
|
| Health Occupations | 4 | 2018 | 226 | 0.180 |
Why?
|
| Homeostasis | 6 | 2018 | 3336 | 0.180 |
Why?
|
| Diabetic Foot | 2 | 2015 | 384 | 0.180 |
Why?
|
| Cataract Extraction | 2 | 2004 | 464 | 0.180 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 2020 | 153 | 0.180 |
Why?
|
| American Heart Association | 5 | 2021 | 1047 | 0.180 |
Why?
|
| Chi-Square Distribution | 8 | 2017 | 3432 | 0.170 |
Why?
|
| Salivary alpha-Amylases | 1 | 2020 | 16 | 0.170 |
Why?
|
| Metagenome | 1 | 2024 | 464 | 0.170 |
Why?
|
| Proteomics | 3 | 2024 | 3910 | 0.170 |
Why?
|
| Taste | 2 | 2013 | 190 | 0.170 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2017 | 1936 | 0.170 |
Why?
|
| Gene Expression Regulation | 9 | 2017 | 11888 | 0.170 |
Why?
|
| Sensitivity and Specificity | 10 | 2019 | 14652 | 0.170 |
Why?
|
| Infant | 15 | 2024 | 36385 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2016 | 4520 | 0.170 |
Why?
|
| Calcium | 6 | 2023 | 5767 | 0.170 |
Why?
|
| Pre-Eclampsia | 2 | 2020 | 1261 | 0.170 |
Why?
|
| Survivors | 5 | 2014 | 2372 | 0.170 |
Why?
|
| Thermogenesis | 1 | 2004 | 496 | 0.170 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2020 | 274 | 0.170 |
Why?
|
| Marital Status | 3 | 2010 | 426 | 0.170 |
Why?
|
| Strontium | 1 | 2019 | 22 | 0.170 |
Why?
|
| Australia | 4 | 2018 | 1258 | 0.170 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2019 | 32 | 0.170 |
Why?
|
| Statistics, Nonparametric | 5 | 2012 | 2845 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 5506 | 0.160 |
Why?
|
| Linoleic Acids | 1 | 2019 | 39 | 0.160 |
Why?
|
| Glycogen | 1 | 2020 | 251 | 0.160 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2010 | 127 | 0.160 |
Why?
|
| Dementia | 2 | 2024 | 2744 | 0.160 |
Why?
|
| Mental Disorders | 1 | 2019 | 6851 | 0.160 |
Why?
|
| Butter | 2 | 2017 | 22 | 0.160 |
Why?
|
| Pipecolic Acids | 1 | 2019 | 78 | 0.160 |
Why?
|
| Zea mays | 1 | 2019 | 110 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 4 | 2007 | 1612 | 0.160 |
Why?
|
| Skinfold Thickness | 3 | 2017 | 164 | 0.160 |
Why?
|
| Nursing Research | 1 | 2020 | 80 | 0.160 |
Why?
|
| RNA-Binding Proteins | 5 | 2015 | 1874 | 0.160 |
Why?
|
| Purines | 2 | 2021 | 615 | 0.160 |
Why?
|
| Mitochondria, Muscle | 1 | 2020 | 170 | 0.160 |
Why?
|
| Gluconeogenesis | 1 | 2020 | 183 | 0.160 |
Why?
|
| ROC Curve | 6 | 2019 | 3620 | 0.160 |
Why?
|
| Quantitative Trait, Heritable | 4 | 2016 | 541 | 0.160 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2446 | 0.160 |
Why?
|
| Ovary | 2 | 2021 | 956 | 0.160 |
Why?
|
| Phobic Disorders | 2 | 2013 | 440 | 0.160 |
Why?
|
| Acute Coronary Syndrome | 3 | 2019 | 2184 | 0.160 |
Why?
|
| Creatinine | 5 | 2018 | 1915 | 0.150 |
Why?
|
| Factor VIII | 1 | 2001 | 347 | 0.150 |
Why?
|
| Cattle | 3 | 2013 | 3801 | 0.150 |
Why?
|
| Time | 2 | 2017 | 550 | 0.150 |
Why?
|
| Sex Characteristics | 8 | 2023 | 2643 | 0.150 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2018 | 6 | 0.150 |
Why?
|
| Respiration Disorders | 1 | 2022 | 362 | 0.150 |
Why?
|
| Vitamin E | 7 | 2009 | 869 | 0.150 |
Why?
|
| India | 8 | 2019 | 2334 | 0.150 |
Why?
|
| Glucosinolates | 1 | 2018 | 11 | 0.150 |
Why?
|
| Epidemiologic Research Design | 2 | 2020 | 368 | 0.150 |
Why?
|
| Lipogenesis | 1 | 2020 | 217 | 0.150 |
Why?
|
| Minerals | 2 | 2014 | 278 | 0.150 |
Why?
|
| Propionates | 1 | 2019 | 180 | 0.150 |
Why?
|
| Twin Studies as Topic | 1 | 1998 | 103 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 3 | 2015 | 898 | 0.150 |
Why?
|
| Infertility, Female | 2 | 2015 | 763 | 0.150 |
Why?
|
| Rest | 1 | 2003 | 941 | 0.150 |
Why?
|
| Salicylates | 1 | 1998 | 125 | 0.150 |
Why?
|
| Hypertriglyceridemia | 3 | 2010 | 290 | 0.150 |
Why?
|
| Colonic Neoplasms | 6 | 2015 | 2531 | 0.150 |
Why?
|
| Boston | 10 | 2024 | 9338 | 0.150 |
Why?
|
| Respiratory Tract Diseases | 2 | 2021 | 744 | 0.150 |
Why?
|
| Carotenoids | 3 | 2022 | 619 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2015 | 2247 | 0.140 |
Why?
|
| Interleukin-13 | 1 | 2020 | 388 | 0.140 |
Why?
|
| Angiotensinogen | 2 | 2009 | 161 | 0.140 |
Why?
|
| Body Fluid Compartments | 1 | 2017 | 48 | 0.140 |
Why?
|
| Developed Countries | 2 | 2012 | 452 | 0.140 |
Why?
|
| Brain | 5 | 2024 | 27178 | 0.140 |
Why?
|
| Air Pollution, Indoor | 4 | 2018 | 931 | 0.140 |
Why?
|
| Data Collection | 2 | 2024 | 3318 | 0.140 |
Why?
|
| Fungal Proteins | 1 | 2001 | 899 | 0.140 |
Why?
|
| Physical Endurance | 1 | 2020 | 368 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2022 | 704 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2016 | 457 | 0.140 |
Why?
|
| Phylogeny | 2 | 2024 | 2832 | 0.140 |
Why?
|
| Heating | 1 | 2018 | 103 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 4 | 2023 | 565 | 0.140 |
Why?
|
| Ribonucleoproteins | 2 | 2017 | 359 | 0.140 |
Why?
|
| Histone Code | 1 | 2018 | 159 | 0.140 |
Why?
|
| Cognition | 7 | 2024 | 7048 | 0.140 |
Why?
|
| Son of Sevenless Proteins | 1 | 2016 | 27 | 0.140 |
Why?
|
| Fibrinogen | 2 | 2015 | 895 | 0.140 |
Why?
|
| Soy Foods | 2 | 2007 | 44 | 0.140 |
Why?
|
| Ascorbic Acid | 3 | 2013 | 657 | 0.140 |
Why?
|
| Osteopontin | 1 | 2019 | 304 | 0.140 |
Why?
|
| Gene Expression | 4 | 2016 | 7584 | 0.140 |
Why?
|
| Palmitoylcarnitine | 1 | 2016 | 3 | 0.140 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2016 | 299 | 0.140 |
Why?
|
| Betaine | 3 | 2024 | 90 | 0.140 |
Why?
|
| Food, Preserved | 1 | 2016 | 12 | 0.140 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2017 | 86 | 0.130 |
Why?
|
| Congresses as Topic | 2 | 2019 | 811 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2015 | 10729 | 0.130 |
Why?
|
| California | 7 | 2015 | 1436 | 0.130 |
Why?
|
| Pandemics | 2 | 2022 | 8701 | 0.130 |
Why?
|
| Israel | 3 | 2024 | 725 | 0.130 |
Why?
|
| Functional Food | 1 | 2016 | 20 | 0.130 |
Why?
|
| United States Government Agencies | 1 | 2016 | 26 | 0.130 |
Why?
|
| Myosins | 1 | 2018 | 408 | 0.130 |
Why?
|
| Albuminuria | 2 | 2011 | 660 | 0.130 |
Why?
|
| Prolactin | 1 | 2018 | 625 | 0.130 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 2 | 2014 | 61 | 0.130 |
Why?
|
| Dehydroepiandrosterone | 1 | 2017 | 248 | 0.130 |
Why?
|
| Sports | 1 | 2002 | 698 | 0.130 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 1999 | 490 | 0.130 |
Why?
|
| Genetic Vectors | 1 | 2006 | 3404 | 0.130 |
Why?
|
| Postpartum Period | 2 | 2020 | 1203 | 0.130 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
| CpG Islands | 2 | 2020 | 1207 | 0.130 |
Why?
|
| Parathyroid Hormone | 3 | 2017 | 1789 | 0.130 |
Why?
|
| Estradiol | 3 | 2012 | 1947 | 0.130 |
Why?
|
| Puerto Rico | 3 | 2024 | 381 | 0.130 |
Why?
|
| Parity | 4 | 2020 | 931 | 0.130 |
Why?
|
| beta Carotene | 3 | 2013 | 522 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 1 | 2001 | 1325 | 0.130 |
Why?
|
| Hydrocarbons, Chlorinated | 2 | 2018 | 120 | 0.130 |
Why?
|
| Glutens | 1 | 2018 | 240 | 0.130 |
Why?
|
| Carrier Proteins | 4 | 2014 | 4913 | 0.130 |
Why?
|
| Sex Hormone-Binding Globulin | 3 | 2016 | 558 | 0.130 |
Why?
|
| Glycolysis | 1 | 2020 | 838 | 0.130 |
Why?
|
| Condiments | 1 | 2015 | 7 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 5 | 2012 | 5786 | 0.130 |
Why?
|
| Margarine | 1 | 2015 | 17 | 0.130 |
Why?
|
| Seasons | 4 | 2015 | 1524 | 0.130 |
Why?
|
| Bone Remodeling | 1 | 2019 | 577 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Publishing | 1 | 2023 | 835 | 0.130 |
Why?
|
| Macular Degeneration | 1 | 2023 | 1014 | 0.130 |
Why?
|
| New Zealand | 1 | 2016 | 359 | 0.120 |
Why?
|
| Oxides | 1 | 2017 | 402 | 0.120 |
Why?
|
| Phenotype | 15 | 2023 | 16721 | 0.120 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2011 | 566 | 0.120 |
Why?
|
| Fluoxetine | 1 | 1999 | 729 | 0.120 |
Why?
|
| Receptors, Neurokinin-3 | 1 | 2015 | 59 | 0.120 |
Why?
|
| Arsenicals | 1 | 2015 | 117 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2005 | 1984 | 0.120 |
Why?
|
| Foot Ulcer | 1 | 2015 | 63 | 0.120 |
Why?
|
| Work | 2 | 2013 | 195 | 0.120 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2014 | 68 | 0.120 |
Why?
|
| Single-Blind Method | 4 | 2013 | 1588 | 0.120 |
Why?
|
| MicroRNAs | 3 | 2018 | 3785 | 0.120 |
Why?
|
| Models, Psychological | 2 | 1999 | 824 | 0.120 |
Why?
|
| Sex Distribution | 5 | 2017 | 2263 | 0.120 |
Why?
|
| Endocrine System Diseases | 1 | 2017 | 243 | 0.120 |
Why?
|
| Infant, Low Birth Weight | 3 | 2016 | 871 | 0.120 |
Why?
|
| Cryptochromes | 1 | 2015 | 49 | 0.120 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 1999 | 878 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2007 | 2041 | 0.120 |
Why?
|
| Malnutrition | 1 | 2021 | 629 | 0.120 |
Why?
|
| Lysine | 1 | 2019 | 991 | 0.120 |
Why?
|
| Child Nutrition Disorders | 1 | 2016 | 139 | 0.120 |
Why?
|
| Carboxy-Lyases | 1 | 2015 | 85 | 0.120 |
Why?
|
| Cataract | 1 | 2001 | 837 | 0.120 |
Why?
|
| PPAR gamma | 3 | 2007 | 483 | 0.120 |
Why?
|
| Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
| Receptors, Transferrin | 2 | 2008 | 300 | 0.120 |
Why?
|
| Health Education | 1 | 2021 | 1060 | 0.120 |
Why?
|
| Treatment Outcome | 21 | 2020 | 65189 | 0.120 |
Why?
|
| Pregnancy, Multiple | 1 | 2015 | 216 | 0.120 |
Why?
|
| Allergens | 4 | 2019 | 1436 | 0.120 |
Why?
|
| Plant Leaves | 2 | 2013 | 154 | 0.120 |
Why?
|
| Acidosis | 1 | 2016 | 271 | 0.120 |
Why?
|
| Hand Strength | 1 | 2017 | 462 | 0.120 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2016 | 291 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2013 | 2329 | 0.120 |
Why?
|
| Restless Legs Syndrome | 1 | 2017 | 235 | 0.120 |
Why?
|
| Pyrazoles | 1 | 2005 | 2033 | 0.120 |
Why?
|
| Severity of Illness Index | 9 | 2019 | 15880 | 0.120 |
Why?
|
| Receptors, Estrogen | 4 | 2013 | 2242 | 0.120 |
Why?
|
| Vanadium | 1 | 2014 | 54 | 0.110 |
Why?
|
| DNA Repair | 2 | 2015 | 2048 | 0.110 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2014 | 49 | 0.110 |
Why?
|
| Immunoassay | 3 | 2018 | 741 | 0.110 |
Why?
|
| Probability | 4 | 2004 | 2475 | 0.110 |
Why?
|
| Diet, Gluten-Free | 1 | 2017 | 285 | 0.110 |
Why?
|
| Peptide Hormones | 1 | 2015 | 133 | 0.110 |
Why?
|
| Hyperlipidemias | 2 | 2012 | 770 | 0.110 |
Why?
|
| Patient Dropouts | 1 | 1996 | 410 | 0.110 |
Why?
|
| Myosin Light Chains | 1 | 2014 | 122 | 0.110 |
Why?
|
| Databases, Factual | 4 | 2018 | 8067 | 0.110 |
Why?
|
| Blood Platelets | 2 | 2015 | 2464 | 0.110 |
Why?
|
| Proteome | 1 | 2024 | 1899 | 0.110 |
Why?
|
| Growth | 1 | 2016 | 365 | 0.110 |
Why?
|
| Quality of Life | 6 | 2020 | 13461 | 0.110 |
Why?
|
| Parents | 4 | 2014 | 3592 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2008 | 591 | 0.110 |
Why?
|
| Contraceptives, Oral | 1 | 2016 | 559 | 0.110 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2002 | 969 | 0.110 |
Why?
|
| Cardiac Myosins | 1 | 2014 | 128 | 0.110 |
Why?
|
| Tooth Loss | 2 | 2012 | 198 | 0.110 |
Why?
|
| Vitamins | 3 | 2014 | 1630 | 0.110 |
Why?
|
| Government Programs | 1 | 2016 | 278 | 0.110 |
Why?
|
| Drug Utilization | 1 | 2019 | 1187 | 0.110 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2014 | 146 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 593 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2015 | 2899 | 0.110 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2016 | 292 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2001 | 2920 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 5 | 2015 | 5444 | 0.110 |
Why?
|
| Science | 1 | 2016 | 234 | 0.110 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2013 | 76 | 0.110 |
Why?
|
| Genetic Determinism | 1 | 2013 | 11 | 0.110 |
Why?
|
| Analysis of Variance | 7 | 2013 | 6203 | 0.110 |
Why?
|
| Population Surveillance | 5 | 2016 | 2590 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2020 | 937 | 0.110 |
Why?
|
| Kidney Diseases | 2 | 2018 | 2098 | 0.110 |
Why?
|
| Manganese | 1 | 2016 | 395 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 1308 | 0.110 |
Why?
|
| Diabetic Nephropathies | 4 | 2009 | 969 | 0.110 |
Why?
|
| Acyltransferases | 1 | 2015 | 305 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2014 | 207 | 0.100 |
Why?
|
| Transition Temperature | 1 | 2013 | 33 | 0.100 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 4353 | 0.100 |
Why?
|
| United States Environmental Protection Agency | 1 | 2013 | 139 | 0.100 |
Why?
|
| Occupational Health Services | 1 | 2014 | 150 | 0.100 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 1304 | 0.100 |
Why?
|
| Dental Caries Susceptibility | 1 | 2012 | 28 | 0.100 |
Why?
|
| G-Protein-Coupled Receptor Kinase 5 | 1 | 2012 | 5 | 0.100 |
Why?
|
| 5'-Nucleotidase | 1 | 2014 | 160 | 0.100 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 353 | 0.100 |
Why?
|
| Respiratory Sounds | 1 | 1997 | 705 | 0.100 |
Why?
|
| Vitamin B Complex | 1 | 2015 | 299 | 0.100 |
Why?
|
| Research Report | 1 | 2016 | 367 | 0.100 |
Why?
|
| zeta-Crystallins | 1 | 2012 | 4 | 0.100 |
Why?
|
| Oxidative Stress | 4 | 2011 | 3141 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2019 | 807 | 0.100 |
Why?
|
| School Health Services | 1 | 1996 | 387 | 0.100 |
Why?
|
| Child Abuse, Sexual | 1 | 2015 | 397 | 0.100 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2018 | 532 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 6 | 2021 | 7425 | 0.100 |
Why?
|
| Osteoarthritis, Knee | 1 | 2023 | 1248 | 0.100 |
Why?
|
| North America | 1 | 2016 | 1285 | 0.100 |
Why?
|
| Flavones | 2 | 2016 | 67 | 0.100 |
Why?
|
| Exhalation | 1 | 2013 | 184 | 0.100 |
Why?
|
| Sucrose | 2 | 2010 | 155 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2018 | 2310 | 0.100 |
Why?
|
| Apolipoprotein B-100 | 2 | 2020 | 157 | 0.100 |
Why?
|
| Malates | 2 | 2023 | 35 | 0.100 |
Why?
|
| Cacao | 1 | 2013 | 98 | 0.100 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3430 | 0.100 |
Why?
|
| Flavonols | 2 | 2016 | 85 | 0.100 |
Why?
|
| Random Allocation | 3 | 2009 | 2395 | 0.100 |
Why?
|
| Prenatal Care | 2 | 2017 | 1159 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2012 | 68 | 0.100 |
Why?
|
| Chromosomes, Human | 2 | 2012 | 437 | 0.100 |
Why?
|
| Premenopause | 5 | 2021 | 1037 | 0.100 |
Why?
|
| Phytotherapy | 2 | 2007 | 298 | 0.100 |
Why?
|
| Immunoglobulins | 1 | 2015 | 852 | 0.100 |
Why?
|
| Urbanization | 1 | 2012 | 101 | 0.100 |
Why?
|
| Vasculitis | 1 | 2016 | 527 | 0.100 |
Why?
|
| Body Constitution | 2 | 2004 | 272 | 0.100 |
Why?
|
| Republic of Korea | 1 | 2014 | 588 | 0.100 |
Why?
|
| Imidazoles | 1 | 2018 | 1162 | 0.100 |
Why?
|
| Abdomen | 3 | 2010 | 1134 | 0.100 |
Why?
|
| Actigraphy | 1 | 2016 | 531 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 595 | 0.100 |
Why?
|
| Ethanol | 2 | 2011 | 1323 | 0.100 |
Why?
|
| Advisory Committees | 1 | 2016 | 796 | 0.100 |
Why?
|
| Proinsulin | 2 | 2017 | 135 | 0.100 |
Why?
|
| Validation Studies as Topic | 2 | 2012 | 162 | 0.100 |
Why?
|
| Tissue Kallikreins | 1 | 2011 | 14 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 261 | 0.090 |
Why?
|
| Sulfotransferases | 1 | 2012 | 151 | 0.090 |
Why?
|
| High Mobility Group Proteins | 1 | 2012 | 180 | 0.090 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2012 | 125 | 0.090 |
Why?
|
| Cognition Disorders | 4 | 2009 | 3967 | 0.090 |
Why?
|
| Vitamin B 12 | 3 | 2016 | 532 | 0.090 |
Why?
|
| Solubility | 2 | 2011 | 1078 | 0.090 |
Why?
|
| Crime Victims | 1 | 2015 | 348 | 0.090 |
Why?
|
| Bicarbonates | 1 | 2012 | 293 | 0.090 |
Why?
|
| Trace Elements | 1 | 2013 | 193 | 0.090 |
Why?
|
| CA-125 Antigen | 1 | 2013 | 283 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2012 | 569 | 0.090 |
Why?
|
| Spouse Abuse | 1 | 2012 | 181 | 0.090 |
Why?
|
| Calcifediol | 1 | 2012 | 156 | 0.090 |
Why?
|
| Agouti Signaling Protein | 1 | 2011 | 22 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 490 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 640 | 0.090 |
Why?
|
| Autoantigens | 1 | 2015 | 883 | 0.090 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2012 | 303 | 0.090 |
Why?
|
| Video Games | 1 | 2013 | 203 | 0.090 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2015 | 504 | 0.090 |
Why?
|
| Behavior | 1 | 2014 | 535 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 7478 | 0.090 |
Why?
|
| Hair Color | 2 | 2009 | 132 | 0.090 |
Why?
|
| Developing Countries | 2 | 2015 | 2911 | 0.090 |
Why?
|
| Commerce | 1 | 2016 | 611 | 0.090 |
Why?
|
| Estrogens | 2 | 2012 | 1529 | 0.090 |
Why?
|
| Sheep | 1 | 2013 | 1440 | 0.090 |
Why?
|
| Phospholipids | 1 | 2014 | 776 | 0.090 |
Why?
|
| Estrone | 1 | 2012 | 234 | 0.090 |
Why?
|
| Costa Rica | 4 | 2013 | 186 | 0.090 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2010 | 33 | 0.090 |
Why?
|
| World Health Organization | 2 | 2023 | 1328 | 0.090 |
Why?
|
| Flax | 1 | 2010 | 10 | 0.090 |
Why?
|
| Cytokines | 4 | 2016 | 7421 | 0.090 |
Why?
|
| Tandem Repeat Sequences | 1 | 2011 | 184 | 0.090 |
Why?
|
| Area Under Curve | 4 | 2019 | 1638 | 0.090 |
Why?
|
| ADAM Proteins | 1 | 2012 | 242 | 0.090 |
Why?
|
| Leisure Activities | 1 | 2012 | 310 | 0.090 |
Why?
|
| Diabetic Neuropathies | 1 | 2014 | 408 | 0.090 |
Why?
|
| Retirement | 1 | 2012 | 198 | 0.090 |
Why?
|
| Antioxidants | 3 | 2003 | 1670 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 854 | 0.090 |
Why?
|
| Plasma | 2 | 2019 | 579 | 0.090 |
Why?
|
| Models, Biological | 3 | 2017 | 9443 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2015 | 23600 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2011 | 311 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2015 | 993 | 0.090 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2010 | 48 | 0.090 |
Why?
|
| Pollen | 2 | 2001 | 79 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 2 | 2013 | 871 | 0.090 |
Why?
|
| Survival | 2 | 2013 | 160 | 0.090 |
Why?
|
| Death Certificates | 2 | 2010 | 170 | 0.090 |
Why?
|
| Likelihood Functions | 4 | 2009 | 993 | 0.090 |
Why?
|
| alpha-Fetoproteins | 2 | 2013 | 226 | 0.090 |
Why?
|
| Saudi Arabia | 3 | 2015 | 211 | 0.080 |
Why?
|
| Cyprus | 1 | 2010 | 96 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2011 | 430 | 0.080 |
Why?
|
| Carbon Monoxide | 1 | 2013 | 560 | 0.080 |
Why?
|
| Blood Specimen Collection | 3 | 2007 | 238 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 494 | 0.080 |
Why?
|
| Cholecalciferol | 1 | 2015 | 550 | 0.080 |
Why?
|
| Genistein | 2 | 2023 | 87 | 0.080 |
Why?
|
| Computers | 1 | 2012 | 588 | 0.080 |
Why?
|
| Lactase | 2 | 2021 | 72 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 360 | 0.080 |
Why?
|
| Riboflavin | 2 | 2023 | 108 | 0.080 |
Why?
|
| Biological Factors | 1 | 2010 | 155 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2020 | 1940 | 0.080 |
Why?
|
| Lysophospholipase | 1 | 2009 | 65 | 0.080 |
Why?
|
| Awareness | 2 | 2011 | 653 | 0.080 |
Why?
|
| Demography | 2 | 2015 | 1641 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2011 | 558 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2017 | 1827 | 0.080 |
Why?
|
| Adenoma | 2 | 2013 | 2152 | 0.080 |
Why?
|
| Transcription Factor AP-2 | 1 | 2009 | 78 | 0.080 |
Why?
|
| Heart | 1 | 2022 | 4414 | 0.080 |
Why?
|
| Observation | 1 | 2011 | 309 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1140 | 0.080 |
Why?
|
| Retrospective Studies | 15 | 2020 | 81515 | 0.080 |
Why?
|
| Mice | 12 | 2024 | 81818 | 0.080 |
Why?
|
| BRCA1 Protein | 1 | 2015 | 1153 | 0.080 |
Why?
|
| Endotoxemia | 1 | 2010 | 198 | 0.080 |
Why?
|
| Resistance Training | 1 | 2011 | 196 | 0.080 |
Why?
|
| Blood Proteins | 1 | 2014 | 1188 | 0.080 |
Why?
|
| Dental Caries | 1 | 2012 | 429 | 0.080 |
Why?
|
| Nevus, Pigmented | 1 | 2011 | 227 | 0.080 |
Why?
|
| Vitamin B 6 | 2 | 2015 | 238 | 0.080 |
Why?
|
| Cluster Analysis | 3 | 2016 | 2720 | 0.080 |
Why?
|
| Genetics, Population | 3 | 2010 | 943 | 0.080 |
Why?
|
| Oral Hygiene | 1 | 2009 | 132 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2008 | 76 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1624 | 0.080 |
Why?
|
| Sunbathing | 1 | 2009 | 66 | 0.080 |
Why?
|
| Skin Neoplasms | 4 | 2011 | 5849 | 0.080 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2009 | 153 | 0.070 |
Why?
|
| Consensus | 1 | 2018 | 3202 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2453 | 0.070 |
Why?
|
| Autonomic Nervous System | 1 | 2013 | 706 | 0.070 |
Why?
|
| Sodium Hypochlorite | 1 | 2008 | 31 | 0.070 |
Why?
|
| Societies, Medical | 2 | 2018 | 3956 | 0.070 |
Why?
|
| omega-N-Methylarginine | 2 | 2018 | 108 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2018 | 2193 | 0.070 |
Why?
|
| Taq Polymerase | 1 | 2007 | 20 | 0.070 |
Why?
|
| Proline | 3 | 2024 | 453 | 0.070 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 453 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2796 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 1672 | 0.070 |
Why?
|
| Citrulline | 2 | 2018 | 106 | 0.070 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 549 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2008 | 110 | 0.070 |
Why?
|
| Goiter | 1 | 2008 | 86 | 0.070 |
Why?
|
| Chromatography, Gas | 1 | 2007 | 151 | 0.070 |
Why?
|
| Reproductive History | 2 | 2021 | 210 | 0.070 |
Why?
|
| Endpoint Determination | 2 | 2013 | 591 | 0.070 |
Why?
|
| Focus Groups | 2 | 2011 | 1459 | 0.070 |
Why?
|
| Telomerase | 1 | 2012 | 749 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2013 | 4044 | 0.070 |
Why?
|
| Research | 1 | 2016 | 1975 | 0.070 |
Why?
|
| Primary Ovarian Insufficiency | 2 | 2021 | 104 | 0.070 |
Why?
|
| Mixed Function Oxygenases | 1 | 2008 | 265 | 0.070 |
Why?
|
| Dipeptides | 1 | 2009 | 387 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 932 | 0.070 |
Why?
|
| Temperance | 2 | 2010 | 88 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2009 | 409 | 0.070 |
Why?
|
| Women | 1 | 2009 | 226 | 0.070 |
Why?
|
| Receptors, Adiponectin | 1 | 2007 | 82 | 0.070 |
Why?
|
| Vascular Diseases | 2 | 2007 | 1159 | 0.070 |
Why?
|
| Occupational Health | 1 | 2013 | 813 | 0.070 |
Why?
|
| Environmental Monitoring | 1 | 2013 | 1470 | 0.070 |
Why?
|
| Students | 1 | 1997 | 1734 | 0.070 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2007 | 113 | 0.070 |
Why?
|
| Antiporters | 1 | 2008 | 275 | 0.070 |
Why?
|
| Reference Standards | 2 | 2013 | 1013 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2012 | 2880 | 0.070 |
Why?
|
| Interferon Regulatory Factors | 1 | 2008 | 271 | 0.070 |
Why?
|
| Child Abuse | 1 | 2015 | 1090 | 0.070 |
Why?
|
| Nitric Oxide | 2 | 2013 | 2143 | 0.070 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2024 | 475 | 0.070 |
Why?
|
| Disinfectants | 1 | 2008 | 130 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2014 | 2195 | 0.070 |
Why?
|
| Autoantibodies | 3 | 2014 | 2113 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 548 | 0.070 |
Why?
|
| Publication Bias | 3 | 2014 | 158 | 0.070 |
Why?
|
| Violence | 1 | 2012 | 935 | 0.070 |
Why?
|
| Dental Care | 1 | 2009 | 286 | 0.070 |
Why?
|
| Lipid Peroxidation | 1 | 2007 | 275 | 0.060 |
Why?
|
| Tetrazolium Salts | 1 | 2006 | 92 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 3046 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 1028 | 0.060 |
Why?
|
| Physical Exertion | 2 | 2006 | 665 | 0.060 |
Why?
|
| Skin Pigmentation | 1 | 2008 | 279 | 0.060 |
Why?
|
| Drug Interactions | 3 | 2005 | 1417 | 0.060 |
Why?
|
| Lipocalins | 1 | 2007 | 162 | 0.060 |
Why?
|
| Mice, Obese | 1 | 2007 | 417 | 0.060 |
Why?
|
| Immunity | 1 | 2012 | 1002 | 0.060 |
Why?
|
| Medical History Taking | 3 | 2010 | 777 | 0.060 |
Why?
|
| Computer Simulation | 1 | 1999 | 6255 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 1490 | 0.060 |
Why?
|
| Neurons | 1 | 2005 | 9524 | 0.060 |
Why?
|
| Quality Control | 4 | 2011 | 837 | 0.060 |
Why?
|
| Social Class | 1 | 2014 | 2007 | 0.060 |
Why?
|
| Adenoviridae | 2 | 2008 | 1092 | 0.060 |
Why?
|
| Iodine | 1 | 2008 | 288 | 0.060 |
Why?
|
| Flavanones | 2 | 2016 | 75 | 0.060 |
Why?
|
| Colorimetry | 1 | 2006 | 148 | 0.060 |
Why?
|
| Aspirin | 2 | 2014 | 3134 | 0.060 |
Why?
|
| Family Characteristics | 1 | 2010 | 1001 | 0.060 |
Why?
|
| MEDLINE | 2 | 2005 | 120 | 0.060 |
Why?
|
| Rheumatoid Factor | 2 | 2017 | 183 | 0.060 |
Why?
|
| Substance-Related Disorders | 3 | 2010 | 4415 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 703 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 3278 | 0.060 |
Why?
|
| Metals, Rare Earth | 1 | 2004 | 16 | 0.060 |
Why?
|
| Diet Fads | 1 | 2004 | 14 | 0.060 |
Why?
|
| Computational Biology | 1 | 2017 | 3559 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2012 | 3160 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 4959 | 0.060 |
Why?
|
| Massachusetts | 4 | 2020 | 8871 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2005 | 108 | 0.060 |
Why?
|
| Genital Diseases, Female | 1 | 2006 | 193 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2005 | 317 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2015 | 4627 | 0.060 |
Why?
|
| Apolipoproteins C | 1 | 2004 | 58 | 0.060 |
Why?
|
| Pigments, Biological | 1 | 2004 | 52 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3672 | 0.060 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2006 | 195 | 0.060 |
Why?
|
| Chloroplasts | 1 | 2004 | 46 | 0.060 |
Why?
|
| Zebrafish | 2 | 2016 | 3035 | 0.060 |
Why?
|
| Poultry | 1 | 2024 | 79 | 0.060 |
Why?
|
| Angina Pectoris | 1 | 2008 | 956 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 4392 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2010 | 951 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2022 | 791 | 0.060 |
Why?
|
| Renin-Angiotensin System | 1 | 2009 | 737 | 0.060 |
Why?
|
| Taxoids | 1 | 2007 | 665 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 3 | 2011 | 2648 | 0.060 |
Why?
|
| Mifepristone | 1 | 2005 | 150 | 0.060 |
Why?
|
| Lipoproteins, LDL | 2 | 2020 | 643 | 0.060 |
Why?
|
| Lumbar Vertebrae | 1 | 2013 | 1873 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2015 | 140 | 0.060 |
Why?
|
| Genomic Imprinting | 2 | 2017 | 326 | 0.060 |
Why?
|
| Glycerophospholipids | 1 | 2023 | 39 | 0.050 |
Why?
|
| Family | 1 | 2014 | 3209 | 0.050 |
Why?
|
| Arteries | 2 | 2006 | 1118 | 0.050 |
Why?
|
| Fertility | 2 | 2021 | 768 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 459 | 0.050 |
Why?
|
| Bacteroidetes | 1 | 2023 | 83 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2006 | 731 | 0.050 |
Why?
|
| Social Environment | 2 | 1999 | 1011 | 0.050 |
Why?
|
| Placebos | 2 | 2020 | 1659 | 0.050 |
Why?
|
| Monosaccharides | 1 | 2023 | 64 | 0.050 |
Why?
|
| Psoriasis | 1 | 2011 | 919 | 0.050 |
Why?
|
| Puberty, Delayed | 1 | 2024 | 124 | 0.050 |
Why?
|
| Molecular Epidemiology | 2 | 2019 | 471 | 0.050 |
Why?
|
| Toes | 1 | 2004 | 209 | 0.050 |
Why?
|
| Plasmalogens | 1 | 2023 | 30 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2007 | 705 | 0.050 |
Why?
|
| Counseling | 1 | 2011 | 1551 | 0.050 |
Why?
|
| Periodicals as Topic | 1 | 2014 | 1462 | 0.050 |
Why?
|
| Drug Therapy | 1 | 2006 | 504 | 0.050 |
Why?
|
| Sphingolipids | 1 | 2024 | 178 | 0.050 |
Why?
|
| Dust | 2 | 2008 | 489 | 0.050 |
Why?
|
| Prostatic Neoplasms | 4 | 2016 | 11083 | 0.050 |
Why?
|
| Fatty Acids, Essential | 1 | 2003 | 97 | 0.050 |
Why?
|
| Poverty | 2 | 2013 | 2714 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2024 | 326 | 0.050 |
Why?
|
| Nucleosides | 1 | 2023 | 130 | 0.050 |
Why?
|
| Oncolytic Virotherapy | 1 | 2008 | 520 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 2218 | 0.050 |
Why?
|
| Islets of Langerhans | 3 | 2015 | 1349 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2019 | 605 | 0.050 |
Why?
|
| tRNA Methyltransferases | 2 | 2016 | 50 | 0.050 |
Why?
|
| Puberty, Precocious | 1 | 2024 | 163 | 0.050 |
Why?
|
| Caspases | 1 | 2006 | 880 | 0.050 |
Why?
|
| Greece | 1 | 2003 | 340 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2341 | 0.050 |
Why?
|
| Databases, Genetic | 3 | 2017 | 1751 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 1661 | 0.050 |
Why?
|
| Cardiology | 1 | 2013 | 1702 | 0.050 |
Why?
|
| Government | 1 | 2023 | 161 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2014 | 6499 | 0.050 |
Why?
|
| Kidney Function Tests | 2 | 2018 | 683 | 0.050 |
Why?
|
| Tanzania | 2 | 2019 | 1407 | 0.050 |
Why?
|
| Air Pollutants | 2 | 2010 | 2923 | 0.050 |
Why?
|
| Aconitic Acid | 1 | 2021 | 13 | 0.050 |
Why?
|
| Interleukins | 1 | 2007 | 791 | 0.050 |
Why?
|
| Isocitrates | 1 | 2021 | 23 | 0.050 |
Why?
|
| Threonine | 1 | 2022 | 272 | 0.050 |
Why?
|
| Linoleoyl-CoA Desaturase | 1 | 2001 | 4 | 0.050 |
Why?
|
| Cholecystectomy | 1 | 2004 | 407 | 0.050 |
Why?
|
| Biophysics | 1 | 2023 | 375 | 0.050 |
Why?
|
| Models, Structural | 1 | 2022 | 338 | 0.050 |
Why?
|
| Hawaii | 1 | 2022 | 101 | 0.050 |
Why?
|
| Antibodies | 1 | 2010 | 2417 | 0.050 |
Why?
|
| Oligomenorrhea | 1 | 2001 | 42 | 0.050 |
Why?
|
| Internationality | 2 | 2019 | 1007 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2004 | 900 | 0.050 |
Why?
|
| Heterozygote | 4 | 2012 | 2794 | 0.050 |
Why?
|
| Rural Health | 2 | 2018 | 301 | 0.050 |
Why?
|
| Menstrual Cycle | 2 | 2002 | 540 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2013 | 1880 | 0.050 |
Why?
|
| Testosterone | 1 | 2012 | 2494 | 0.050 |
Why?
|
| Jogging | 2 | 2013 | 17 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2017 | 697 | 0.050 |
Why?
|
| Vietnam | 2 | 2003 | 411 | 0.050 |
Why?
|
| Exons | 1 | 2007 | 2391 | 0.050 |
Why?
|
| Heart Diseases | 2 | 2013 | 2821 | 0.050 |
Why?
|
| Calibration | 1 | 2024 | 814 | 0.050 |
Why?
|
| Palmitic Acid | 1 | 2022 | 147 | 0.050 |
Why?
|
| DNA Primers | 1 | 2006 | 2825 | 0.050 |
Why?
|
| Isoleucine | 1 | 2021 | 109 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2312 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1341 | 0.050 |
Why?
|
| Transcription Factors | 4 | 2008 | 12131 | 0.050 |
Why?
|
| Adipocytes | 1 | 2008 | 1194 | 0.050 |
Why?
|
| Citric Acid | 1 | 2021 | 124 | 0.050 |
Why?
|
| Combined Modality Therapy | 4 | 2020 | 8529 | 0.050 |
Why?
|
| Sarcosine | 1 | 2021 | 16 | 0.050 |
Why?
|
| Urinary Incontinence | 1 | 2005 | 491 | 0.050 |
Why?
|
| Pyridoxine | 2 | 1999 | 108 | 0.050 |
Why?
|
| Liver Cirrhosis | 2 | 2023 | 1959 | 0.050 |
Why?
|
| Prebiotics | 1 | 2021 | 41 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 22331 | 0.050 |
Why?
|
| Patient Education as Topic | 3 | 2010 | 2334 | 0.050 |
Why?
|
| Succinic Acid | 1 | 2021 | 86 | 0.050 |
Why?
|
| Length of Stay | 1 | 2015 | 6485 | 0.050 |
Why?
|
| Nova Scotia | 1 | 2020 | 33 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 1077 | 0.050 |
Why?
|
| Combat Disorders | 1 | 2003 | 300 | 0.050 |
Why?
|
| Prevotella | 1 | 2021 | 81 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 2003 | 448 | 0.040 |
Why?
|
| Gene Expression Profiling | 6 | 2013 | 9524 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 114 | 0.040 |
Why?
|
| Periodicity | 1 | 2002 | 345 | 0.040 |
Why?
|
| Adaptation, Psychological | 2 | 2021 | 2660 | 0.040 |
Why?
|
| DNA | 4 | 2023 | 7202 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 9601 | 0.040 |
Why?
|
| Interleukin-13 Receptor alpha1 Subunit | 1 | 2020 | 23 | 0.040 |
Why?
|
| Multifactorial Inheritance | 2 | 2024 | 1425 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2010 | 6014 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2015 | 9373 | 0.040 |
Why?
|
| Thyroid Nodule | 1 | 2008 | 779 | 0.040 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2001 | 197 | 0.040 |
Why?
|
| Schistosomiasis japonica | 1 | 2000 | 3 | 0.040 |
Why?
|
| Progestins | 1 | 2002 | 300 | 0.040 |
Why?
|
| Spores | 1 | 2000 | 14 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 1892 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2007 | 1728 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2006 | 1136 | 0.040 |
Why?
|
| Calcium Channels, T-Type | 1 | 2000 | 28 | 0.040 |
Why?
|
| Pneumonia | 1 | 2012 | 2157 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2011 | 323 | 0.040 |
Why?
|
| Horses | 1 | 2020 | 293 | 0.040 |
Why?
|
| Flour | 1 | 2019 | 22 | 0.040 |
Why?
|
| Glutarates | 1 | 2021 | 243 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2015 | 3853 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2017 | 12437 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 36532 | 0.040 |
Why?
|
| Leucine | 1 | 2021 | 546 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 1 | 2020 | 198 | 0.040 |
Why?
|
| Iran | 3 | 2007 | 761 | 0.040 |
Why?
|
| Fossil Fuels | 1 | 2020 | 53 | 0.040 |
Why?
|
| Bayes Theorem | 2 | 2023 | 2354 | 0.040 |
Why?
|
| Calcium Channels | 2 | 2004 | 622 | 0.040 |
Why?
|
| Diterpenes | 1 | 2020 | 166 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2012 | 281 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1599 | 0.040 |
Why?
|
| Peer Group | 2 | 1996 | 701 | 0.040 |
Why?
|
| Twins | 1 | 2001 | 341 | 0.040 |
Why?
|
| Occupational Exposure | 2 | 2021 | 1805 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2004 | 1515 | 0.040 |
Why?
|
| Electricity | 1 | 2020 | 174 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2001 | 711 | 0.040 |
Why?
|
| Fish Proteins | 1 | 2019 | 48 | 0.040 |
Why?
|
| Serine | 1 | 2022 | 824 | 0.040 |
Why?
|
| Myoblasts | 1 | 2020 | 234 | 0.040 |
Why?
|
| Algorithms | 2 | 2018 | 14071 | 0.040 |
Why?
|
| Erectile Dysfunction | 1 | 2002 | 437 | 0.040 |
Why?
|
| Genes, ras | 1 | 2001 | 658 | 0.040 |
Why?
|
| Particulate Matter | 1 | 2010 | 2624 | 0.040 |
Why?
|
| Educational Status | 2 | 2021 | 2513 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4562 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 1999 | 258 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2001 | 465 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2011 | 3710 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2008 | 4528 | 0.040 |
Why?
|
| Pyrenes | 1 | 2018 | 51 | 0.040 |
Why?
|
| Genetic Heterogeneity | 2 | 2013 | 735 | 0.040 |
Why?
|
| Tonometry, Ocular | 1 | 2019 | 238 | 0.040 |
Why?
|
| Apolipoproteins | 1 | 2020 | 327 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2008 | 5993 | 0.040 |
Why?
|
| Antimony | 1 | 2018 | 20 | 0.040 |
Why?
|
| Phenanthrenes | 1 | 2018 | 65 | 0.040 |
Why?
|
| Phospholipid Ethers | 1 | 2017 | 8 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3584 | 0.040 |
Why?
|
| Leukocyte Count | 2 | 2014 | 1602 | 0.040 |
Why?
|
| Oleic Acid | 1 | 2018 | 88 | 0.040 |
Why?
|
| Oleic Acids | 1 | 2018 | 70 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2018 | 102 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 1999 | 416 | 0.040 |
Why?
|
| Helicobacter pylori | 1 | 2001 | 380 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1524 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2001 | 390 | 0.040 |
Why?
|
| Mutation, Missense | 3 | 2015 | 2589 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2009 | 2736 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2024 | 1369 | 0.040 |
Why?
|
| Oxygenases | 1 | 2017 | 59 | 0.040 |
Why?
|
| Blood Banks | 1 | 2018 | 108 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 661 | 0.040 |
Why?
|
| Herpesvirus 1, Human | 1 | 2003 | 743 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2017 | 151 | 0.030 |
Why?
|
| Copper | 1 | 2019 | 367 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2008 | 18973 | 0.030 |
Why?
|
| Pedigree | 2 | 2019 | 4526 | 0.030 |
Why?
|
| Probiotics | 1 | 2021 | 387 | 0.030 |
Why?
|
| Dreams | 1 | 1998 | 144 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2017 | 81 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6220 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2019 | 453 | 0.030 |
Why?
|
| Atrophy | 1 | 2022 | 1635 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 1406 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 1241 | 0.030 |
Why?
|
| Biometry | 1 | 2000 | 571 | 0.030 |
Why?
|
| DNA Helicases | 2 | 2012 | 852 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 135 | 0.030 |
Why?
|
| Artifacts | 2 | 2018 | 1893 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2017 | 166 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2020 | 365 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 1999 | 651 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2006 | 2033 | 0.030 |
Why?
|
| United States Department of Agriculture | 1 | 2016 | 47 | 0.030 |
Why?
|
| Sputum | 1 | 1999 | 513 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2004 | 1226 | 0.030 |
Why?
|
| Sweden | 2 | 2014 | 1381 | 0.030 |
Why?
|
| Naphthols | 1 | 2016 | 45 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2015 | 3537 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2018 | 611 | 0.030 |
Why?
|
| Disease-Free Survival | 3 | 2012 | 6832 | 0.030 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2016 | 88 | 0.030 |
Why?
|
| State Medicine | 1 | 2017 | 219 | 0.030 |
Why?
|
| Nursing Staff | 1 | 2017 | 113 | 0.030 |
Why?
|
| Dinucleoside Phosphates | 1 | 2016 | 71 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 870 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13400 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2001 | 1146 | 0.030 |
Why?
|
| Finland | 1 | 2017 | 608 | 0.030 |
Why?
|
| Caffeic Acids | 1 | 2015 | 9 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 1668 | 0.030 |
Why?
|
| Environmental Pollution | 1 | 1997 | 125 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 173 | 0.030 |
Why?
|
| Coumaric Acids | 1 | 2015 | 13 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2007 | 5526 | 0.030 |
Why?
|
| Rats | 4 | 2005 | 23707 | 0.030 |
Why?
|
| Introns | 1 | 2018 | 966 | 0.030 |
Why?
|
| Endometrial Neoplasms | 2 | 2015 | 1378 | 0.030 |
Why?
|
| Running | 1 | 2020 | 488 | 0.030 |
Why?
|
| Systole | 1 | 2017 | 935 | 0.030 |
Why?
|
| Myocardium | 1 | 2008 | 4760 | 0.030 |
Why?
|
| Hesperidin | 1 | 2015 | 19 | 0.030 |
Why?
|
| Diastole | 1 | 2017 | 785 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2010 | 1216 | 0.030 |
Why?
|
| Titanium | 1 | 2018 | 490 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2022 | 1078 | 0.030 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2015 | 91 | 0.030 |
Why?
|
| Catechin | 1 | 2015 | 69 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2016 | 139 | 0.030 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2014 | 32 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2015 | 129 | 0.030 |
Why?
|
| Spores, Fungal | 2 | 2008 | 90 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 286 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2023 | 1303 | 0.030 |
Why?
|
| Fatigue | 1 | 2022 | 1549 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2003 | 17594 | 0.030 |
Why?
|
| Quercetin | 1 | 2015 | 97 | 0.030 |
Why?
|
| Alcoholism | 2 | 2014 | 1975 | 0.030 |
Why?
|
| Policy Making | 1 | 2018 | 546 | 0.030 |
Why?
|
| Syndrome | 1 | 2001 | 3271 | 0.030 |
Why?
|
| Chromosome Aberrations | 2 | 2011 | 1774 | 0.030 |
Why?
|
| Knee Joint | 1 | 2023 | 1656 | 0.030 |
Why?
|
| Arsenic | 1 | 2018 | 356 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 59 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4165 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 1999 | 622 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 508 | 0.030 |
Why?
|
| Videodisc Recording | 1 | 2013 | 14 | 0.030 |
Why?
|
| Netherlands | 2 | 2010 | 2277 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 56 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 777 | 0.030 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2014 | 58 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 2017 | 547 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 288 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 2015 | 229 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2006 | 2159 | 0.030 |
Why?
|
| Species Specificity | 2 | 2013 | 2406 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 229 | 0.030 |
Why?
|
| Erythrocyte Membrane | 1 | 2015 | 429 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 208 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 814 | 0.030 |
Why?
|
| Penetrance | 1 | 2015 | 388 | 0.030 |
Why?
|
| Prunus | 1 | 2013 | 12 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2007 | 2895 | 0.030 |
Why?
|
| Macrophages | 1 | 2008 | 5772 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2015 | 319 | 0.030 |
Why?
|
| Family Health | 1 | 2018 | 1253 | 0.030 |
Why?
|
| Nuclear Family | 1 | 2014 | 311 | 0.030 |
Why?
|
| Food Contamination | 1 | 2014 | 194 | 0.030 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2013 | 28 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 523 | 0.030 |
Why?
|
| Urinalysis | 1 | 2015 | 368 | 0.030 |
Why?
|
| Hospitals, Rural | 1 | 2015 | 175 | 0.030 |
Why?
|
| Cysteine | 1 | 2018 | 898 | 0.030 |
Why?
|
| DMF Index | 1 | 2012 | 86 | 0.030 |
Why?
|
| Dentition, Permanent | 1 | 2012 | 22 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3737 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2015 | 382 | 0.030 |
Why?
|
| Hysterectomy | 1 | 2018 | 864 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 845 | 0.030 |
Why?
|
| Selenoproteins | 1 | 2014 | 216 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 857 | 0.030 |
Why?
|
| Inhibin-beta Subunits | 1 | 2012 | 27 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 493 | 0.030 |
Why?
|
| Income | 1 | 2021 | 1874 | 0.030 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2012 | 35 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 1481 | 0.030 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1999 | 1727 | 0.030 |
Why?
|
| Amides | 1 | 2015 | 455 | 0.030 |
Why?
|
| CA-19-9 Antigen | 1 | 2013 | 109 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2001 | 1203 | 0.030 |
Why?
|
| Neutron Activation Analysis | 1 | 2012 | 35 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 1327 | 0.030 |
Why?
|
| Louisiana | 1 | 2012 | 104 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2018 | 4137 | 0.030 |
Why?
|
| Pyrus | 1 | 2012 | 14 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 792 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2018 | 8733 | 0.020 |
Why?
|
| Melanoma | 1 | 2011 | 5719 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 1833 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 2013 | 136 | 0.020 |
Why?
|
| Societies, Scientific | 1 | 2013 | 221 | 0.020 |
Why?
|
| Doxorubicin | 1 | 1999 | 2230 | 0.020 |
Why?
|
| Breath Tests | 1 | 2013 | 297 | 0.020 |
Why?
|
| Videotape Recording | 1 | 2013 | 331 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 714 | 0.020 |
Why?
|
| Transients and Migrants | 1 | 2015 | 170 | 0.020 |
Why?
|
| Drug Utilization Review | 1 | 2013 | 248 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 1526 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 139 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 323 | 0.020 |
Why?
|
| Anthocyanins | 1 | 2012 | 80 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2011 | 112 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2012 | 184 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2001 | 1168 | 0.020 |
Why?
|
| Vitamin A | 1 | 2015 | 610 | 0.020 |
Why?
|
| DNA Damage | 1 | 2001 | 2457 | 0.020 |
Why?
|
| Cell Line | 3 | 2020 | 15543 | 0.020 |
Why?
|
| Cocaine | 1 | 1997 | 946 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2016 | 12769 | 0.020 |
Why?
|
| Malus | 1 | 2012 | 50 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2015 | 395 | 0.020 |
Why?
|
| Dancing | 1 | 2013 | 105 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2013 | 337 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 300 | 0.020 |
Why?
|
| DNA Primase | 1 | 2012 | 110 | 0.020 |
Why?
|
| DNA Copy Number Variations | 2 | 2010 | 2045 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 1997 | 879 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 386 | 0.020 |
Why?
|
| Culture | 1 | 2015 | 622 | 0.020 |
Why?
|
| Transferrin | 1 | 2012 | 283 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2006 | 3213 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2013 | 327 | 0.020 |
Why?
|
| Scotland | 1 | 2011 | 115 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2012 | 204 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 13648 | 0.020 |
Why?
|
| Reproduction | 1 | 2015 | 641 | 0.020 |
Why?
|
| Epigenomics | 1 | 2017 | 959 | 0.020 |
Why?
|
| Poultry Products | 1 | 2010 | 10 | 0.020 |
Why?
|
| Midwestern United States | 1 | 2010 | 70 | 0.020 |
Why?
|
| Bread | 1 | 2010 | 23 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 2674 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2021 | 2554 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1999 | 2203 | 0.020 |
Why?
|
| Fish Products | 1 | 2010 | 31 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 3251 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2001 | 8278 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 568 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 191 | 0.020 |
Why?
|
| Genes, Recessive | 2 | 2006 | 624 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2011 | 371 | 0.020 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2010 | 116 | 0.020 |
Why?
|
| Mitochondria | 2 | 2016 | 3673 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Pigmentation | 1 | 2011 | 143 | 0.020 |
Why?
|
| Bacteria | 1 | 2021 | 2209 | 0.020 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 265 | 0.020 |
Why?
|
| Twins, Monozygotic | 2 | 2003 | 469 | 0.020 |
Why?
|
| Wakefulness | 1 | 2017 | 1282 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 342 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 1997 | 1096 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 116 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 920 | 0.020 |
Why?
|
| Acute Disease | 2 | 2014 | 7232 | 0.020 |
Why?
|
| Social Change | 1 | 2010 | 152 | 0.020 |
Why?
|
| Nigeria | 1 | 2012 | 782 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2015 | 884 | 0.020 |
Why?
|
| Sunlight | 1 | 2011 | 337 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2015 | 1441 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 175 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 2010 | 163 | 0.020 |
Why?
|
| Tai Ji | 1 | 2013 | 289 | 0.020 |
Why?
|
| Periodontal Index | 1 | 2009 | 149 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 17075 | 0.020 |
Why?
|
| Hypogonadism | 1 | 2015 | 801 | 0.020 |
Why?
|
| Population Groups | 1 | 2010 | 209 | 0.020 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 77 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2009 | 76 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 384 | 0.020 |
Why?
|
| Incretins | 1 | 2010 | 100 | 0.020 |
Why?
|
| Recurrence | 2 | 2011 | 8501 | 0.020 |
Why?
|
| Lung Neoplasms | 3 | 2010 | 13451 | 0.020 |
Why?
|
| Point Mutation | 2 | 2007 | 1590 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2011 | 222 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 482 | 0.020 |
Why?
|
| Memory | 2 | 2009 | 2190 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 1999 | 1471 | 0.020 |
Why?
|
| Cystatin C | 1 | 2010 | 272 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2024 | 4533 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2013 | 929 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 11206 | 0.020 |
Why?
|
| Sex Offenses | 1 | 2012 | 356 | 0.020 |
Why?
|
| Genes | 1 | 2012 | 1825 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2010 | 345 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2012 | 660 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2016 | 2761 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1999 | 2942 | 0.020 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2009 | 169 | 0.020 |
Why?
|
| Intestines | 1 | 2017 | 1906 | 0.020 |
Why?
|
| Goiter, Nodular | 1 | 2008 | 28 | 0.020 |
Why?
|
| Physical Examination | 1 | 2014 | 1266 | 0.020 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2010 | 291 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 743 | 0.020 |
Why?
|
| Ovarian Neoplasms | 2 | 2015 | 4900 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2008 | 281 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2001 | 3837 | 0.020 |
Why?
|
| Sexual Partners | 1 | 2012 | 804 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4108 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 1999 | 2207 | 0.020 |
Why?
|
| Stents | 1 | 1999 | 3213 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2013 | 1006 | 0.020 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2010 | 303 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2008 | 247 | 0.020 |
Why?
|
| New England | 1 | 2010 | 1059 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 326 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2015 | 2739 | 0.020 |
Why?
|
| Air Microbiology | 1 | 2008 | 94 | 0.020 |
Why?
|
| Kaempferols | 1 | 2007 | 22 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 2008 | 282 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 1238 | 0.020 |
Why?
|
| British Columbia | 1 | 2007 | 237 | 0.020 |
Why?
|
| Brassica | 1 | 2007 | 40 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 8728 | 0.020 |
Why?
|
| Thorax | 1 | 2010 | 554 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2009 | 784 | 0.020 |
Why?
|
| Ketone Bodies | 1 | 2007 | 75 | 0.020 |
Why?
|
| Thyroid Function Tests | 1 | 2008 | 293 | 0.020 |
Why?
|
| Air Pollution | 1 | 2001 | 2380 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 6001 | 0.020 |
Why?
|
| Serum Amyloid A Protein | 1 | 2007 | 127 | 0.020 |
Why?
|
| Potassium Channels | 1 | 2009 | 534 | 0.020 |
Why?
|
| Neutrophils | 1 | 1999 | 3776 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1749 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2832 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2010 | 578 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 1631 | 0.020 |
Why?
|
| Chicago | 1 | 2007 | 255 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2008 | 898 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2011 | 633 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 2927 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2008 | 644 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1509 | 0.020 |
Why?
|
| Hunger | 1 | 2007 | 207 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 5783 | 0.020 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 376 | 0.020 |
Why?
|
| Mental Health | 2 | 2010 | 3272 | 0.020 |
Why?
|
| Leg | 1 | 2010 | 1080 | 0.020 |
Why?
|
| Phenylethanolamine N-Methyltransferase | 1 | 2004 | 18 | 0.010 |
Why?
|
| Perception | 1 | 2011 | 1205 | 0.010 |
Why?
|
| Chlorophyll | 1 | 2004 | 30 | 0.010 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2004 | 30 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2004 | 52 | 0.010 |
Why?
|
| Oncolytic Viruses | 1 | 2008 | 344 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14447 | 0.010 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2004 | 66 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 1731 | 0.010 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2004 | 31 | 0.010 |
Why?
|
| Patient Selection | 2 | 2009 | 4255 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2485 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2015 | 2968 | 0.010 |
Why?
|
| Widowhood | 1 | 2004 | 51 | 0.010 |
Why?
|
| Tritium | 1 | 2004 | 702 | 0.010 |
Why?
|
| Divorce | 1 | 2004 | 78 | 0.010 |
Why?
|
| Specialization | 1 | 2009 | 777 | 0.010 |
Why?
|
| Fats, Unsaturated | 1 | 2003 | 21 | 0.010 |
Why?
|
| Gastrectomy | 1 | 2009 | 694 | 0.010 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 1882 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 975 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2004 | 365 | 0.010 |
Why?
|
| Lutein | 1 | 2003 | 123 | 0.010 |
Why?
|
| Brazil | 1 | 2007 | 1248 | 0.010 |
Why?
|
| Reimbursement Mechanisms | 1 | 2009 | 672 | 0.010 |
Why?
|
| alpha-Tocopherol | 1 | 2003 | 127 | 0.010 |
Why?
|
| Expert Testimony | 1 | 2005 | 266 | 0.010 |
Why?
|
| Endothelium | 1 | 2005 | 767 | 0.010 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2005 | 409 | 0.010 |
Why?
|
| Blinking | 1 | 2003 | 135 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2007 | 1828 | 0.010 |
Why?
|
| Colectomy | 1 | 2007 | 697 | 0.010 |
Why?
|
| Software | 1 | 2016 | 4462 | 0.010 |
Why?
|
| Opioid-Related Disorders | 1 | 1997 | 2178 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3596 | 0.010 |
Why?
|
| Symporters | 1 | 2004 | 362 | 0.010 |
Why?
|
| Swine | 1 | 2011 | 5988 | 0.010 |
Why?
|
| Emotions | 1 | 2013 | 2763 | 0.010 |
Why?
|
| Poaceae | 1 | 2001 | 24 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2013 | 1530 | 0.010 |
Why?
|
| Animals, Domestic | 1 | 2001 | 55 | 0.010 |
Why?
|
| Mites | 1 | 2001 | 46 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1999 | 6364 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6069 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1083 | 0.010 |
Why?
|
| Kansas | 1 | 2001 | 37 | 0.010 |
Why?
|
| Missouri | 1 | 2001 | 113 | 0.010 |
Why?
|
| Trees | 1 | 2001 | 58 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 2008 | 1180 | 0.010 |
Why?
|
| Antigens, Fungal | 1 | 2001 | 69 | 0.010 |
Why?
|
| Cockroaches | 1 | 2001 | 93 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18294 | 0.010 |
Why?
|
| Chemoprevention | 1 | 2003 | 327 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 11868 | 0.010 |
Why?
|
| Calcinosis | 1 | 2009 | 1479 | 0.010 |
Why?
|
| Galvanic Skin Response | 1 | 2003 | 359 | 0.010 |
Why?
|
| Alanine | 1 | 2003 | 612 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2015 | 5343 | 0.010 |
Why?
|
| Gastric Bypass | 1 | 2009 | 820 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 2001 | 236 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2001 | 614 | 0.010 |
Why?
|
| Pacific Islands | 1 | 1999 | 52 | 0.010 |
Why?
|
| Insect Proteins | 1 | 2001 | 253 | 0.010 |
Why?
|
| Cats | 1 | 2001 | 972 | 0.010 |
Why?
|
| Ion Channels | 1 | 2004 | 1045 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 1999 | 107 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 2887 | 0.010 |
Why?
|
| Documentation | 1 | 2006 | 916 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 201 | 0.010 |
Why?
|
| Drug Costs | 1 | 2007 | 1193 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1999 | 173 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 1740 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 2428 | 0.010 |
Why?
|
| Anemia | 1 | 2008 | 1511 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 1237 | 0.010 |
Why?
|
| Homozygote | 1 | 2003 | 1775 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7599 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 238 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 1999 | 215 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2171 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1999 | 766 | 0.010 |
Why?
|
| Urban Health | 1 | 2001 | 530 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2009 | 3097 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2003 | 1255 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 2001 | 334 | 0.010 |
Why?
|
| Proteinuria | 1 | 2001 | 607 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2008 | 2115 | 0.010 |
Why?
|
| Electromyography | 1 | 2003 | 1399 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3796 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2009 | 2517 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 1999 | 455 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 1999 | 834 | 0.010 |
Why?
|
| P-Selectin | 1 | 1999 | 597 | 0.010 |
Why?
|
| Mutation | 1 | 2001 | 30196 | 0.010 |
Why?
|
| Cell Count | 1 | 2001 | 1823 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1999 | 856 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 1999 | 918 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2004 | 1406 | 0.010 |
Why?
|
| Albumins | 1 | 1999 | 577 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 3822 | 0.010 |
Why?
|
| Magnetics | 1 | 1999 | 585 | 0.010 |
Why?
|
| Microspheres | 1 | 1999 | 773 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15747 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2001 | 924 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 2086 | 0.010 |
Why?
|
| Disease | 1 | 2001 | 676 | 0.010 |
Why?
|
| Medical Records | 1 | 2001 | 1409 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2007 | 2567 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1999 | 1243 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1999 | 1884 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 8611 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 1718 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 5743 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20660 | 0.010 |
Why?
|
| Observer Variation | 1 | 2001 | 2615 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2000 | 1107 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1999 | 1520 | 0.010 |
Why?
|
| Cell Death | 1 | 1999 | 1679 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 1999 | 2105 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 4159 | 0.010 |
Why?
|
| Base Sequence | 1 | 2000 | 12403 | 0.000 |
Why?
|
| Radiography | 1 | 1999 | 6919 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 8102 | 0.000 |
Why?
|
| Registries | 1 | 2003 | 8297 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1999 | 3800 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 11022 | 0.000 |
Why?
|
| HIV-1 | 1 | 1999 | 6944 | 0.000 |
Why?
|